[8.12652587890625, 10.666244506835938, "Great 60% of med students don\u2019t plan on taking care of patients.  \n\nWhen I get older and sicker I will have a plethora of thought leaders and administers at my disposal.\n\n1 in 4 US medical students consider quitting, most don\u2019t plan to treat patients:  https://t.co/6oyDsz69kI"]
[9.979496002197266, 7.537386894226074, "RT @jamecancerdoc: Great costume  @JaneMTay of @AaronGoodman33 \ud83d\ude00 the other guy is my son \ud83d\ude00 why he didn\u2019t dress up like me !!"]
[8.031207084655762, 13.524901390075684, "Amazing a bispecific antibodies can lower a protein in the blood in asymptomatic \u201cpatients\u201d\n#ASH22\n\nPaper: Immuno-PRISM: A Randomized Phase II Platform Study of Bispecific Antibodies in High-Risk Smoldering Myeloma https://t.co/B8GmNsMjuu"]
[5.846466064453125, 9.634214401245117, "I always love vitamin D randomized trials.  Run 20 more and one will be positive.\n\nPaper: Ilyad: A Phase III Double Blind, Randomized Trial Evaluating Vitamin D (Cholecalciferol) in Patients with Low Tumor-Burden Indolent Non-Hodgkin Lymphoma https://t.co/ZTdHZtrQjJ"]
[9.513504981994629, 8.247821807861328, "@liamgallagher If the Beatles can reunite over 50 years later with two band members in heaven I think Oasis should be able to get something together."]
[10.519903182983398, 10.438864707946777, "#ASH23 abstracts are out!  Please fill my twitter feed with important abstracts and commentary.  These are my favorite few months in this platform.\n\n65th ASH Annual Meeting &amp; Exposition https://t.co/aedT5DTGIA"]
[9.342206954956055, 7.632666110992432, "@AshleyGWinter DMs to me have taken a sad change over the last few weeks."]
[8.46911907196045, 8.007257461547852, "@adamcifu I nominate @DavidSteensma to write"]
[6.731532096862793, 12.055005073547363, "They should develop trials looking at Belantamab for eyeball cancer. https://t.co/9SpaZQIRLn"]
[9.205652236938477, 7.545917987823486, "@sanamloghavi @MDAndersonNews Sign me up."]
[8.318084716796875, 10.688207626342773, "When work gets super stressful just remember all that really matters.\n\nTaking care of your patients\nTaking care of your family"]
[8.185349464416504, 10.124008178710938, "I have been an attending oncologist for over 6 years and the final \u201cgoodbye\u201d when a longterm patient/friend goes home on hospice is still a unique experience words can not adequately describe.  I still never know quite what to say. I can't imagine what it is like for the patient."]
[8.673151969909668, 13.955221176147461, "For my fellow attendings when the medical students asks you to go over the MRI findings on rounds\n\nhttps://t.co/PSP03jhIuO https://t.co/F3FhOWYhgx"]
[6.968491077423096, 9.197964668273926, "Excited to  teach my colleagues in Ukraine some lymphoma and what a good taco is tomorrow!\n\nAlso I didn't know my name is Ukrainian is AApoH.  I like it. https://t.co/33cQrqQeVy"]
[6.299737453460693, 12.051115989685059, "RT @ManniMD1: Describing this trial of teclistamab in smoldering MM to pts:\ud83d\ude1f\n\nYou may not need treatment for yrs. When you do need tx, you\u2026"]
[10.992574691772461, 8.363123893737793, "Good point https://t.co/FmzLlVSCN1"]
[8.551706314086914, 9.647509574890137, "@RenoHemonc @medmalreviewer Oh I am aware one of his cases was me (Dr. Goodman success though)"]
[7.931419372558594, 11.250875473022461, "These days inpatient and ER medicine has just become order every test, over diagnose, and over treat.  So many incidental findings chased."]
[6.9572978019714355, 10.196839332580566, "@graham74GC I will say anecdotally I have had some good outcomes with CART."]
[10.69272232055664, 12.24325942993164, "Iron Deficiency Differential Diagnosis Table! \n\nMany have tried to make this table, however, I assure you this is the most complete and best version [courtesy of ASH Education Book]!\n\nhttps://t.co/E1aBzlaEo8\u2026\u2026 https://t.co/YPF5nzKO2N"]
[10.029202461242676, 12.426798820495605, "AML Heme Path Pearl!\n\nAML with t(6;9) [DEK-NUP214]\n\n1% of AMLs\nAssociated with basophilia!\nFrequent FLT3 ITD mutations\n\nPoor prognosis (5 year OS = 30%)\nRx = intensive induction +/- FLT3 inhibitor or ven/aza\nConsolidate = allogeneic transplant if able.\n\nhttps://t.co/LDmZ7I09oZ https://t.co/WUK4n4dgLb"]
[6.615667343139648, 9.724983215332031, "@VPrasadMDMPH Fit patient with poor risk AML/MDS = yes\nFit patient with refractory T-cell lymphoma = yes\nFit patient with chemo sensitive relapsed DLBCL = yes\n\nEverything else, I don't really know"]
[8.592013359069824, 9.767414093017578, "I don\u2019t know who Dr. Sabatine is but he knows how to write a damn good concise book. https://t.co/4HhFpCHL5h"]
[10.61211109161377, 12.293261528015137, "The Stages of Iron Deficiency!\n\nIron depletion = normal hemoglobin and MCV! \n\nIron-restricted erythropoiesis = MVC starts going down but hemoglobin normal.  \n\nIron deficiency anemia = MCV and hemoglobin go down https://t.co/xduoONUXWU"]
[6.733068466186523, 10.824172973632812, "@dgermain21 30 percent isn\u2019t horrible. Ive been giving hd mtx to get cns in remission then cart"]
[9.423404693603516, 10.688693046569824, "Any jobs available where I can just round on inpatient BMT all day and teach and have no clinic, research, or administrative responsibilities?"]
[7.886394500732422, 12.554108619689941, "von Willebrand disease type 2A and TTP are opposites!  \n\nvWD 2A =\n\u2b07\ufe0fVWF large multimer (cut up too much by\nADAMTS13)\n\u2b07\ufe0fbinding to platelets =\u2b06\ufe0f bleeding\n\nTTP = Autoantibody to ADAMTS13 (or in congenital not made)\n\u2b06\ufe0fVWF large multimers (not cut up)\n\u2b06\ufe0f platelet binding = thrombosis https://t.co/rmri3tU6lI"]
[9.965103149414062, 12.438542366027832, "Passenger Lymphocyte Syndrome!\n\nB cells in allograft produce allo Abs against residual recipient RBCs  \nDAT+ hemolytic anemia \nBrisk hemolysis days +5-15 after transplant  \nOccurs= Minor incompatibility allo-SCT (donor O recipient A) \n\nMore frequent in NMA Tx  and Solid organ Tx https://t.co/XjGtrGDHv5"]
[8.806396484375, 9.276575088500977, "@jbcarmody @DGlaucomflecken Every admissions committee I sit on usually prioritizes research.  I get hundreds of emails a year from college students,  med students, residents (even high school students asking to do research.  Going to take a lot to shift this culture."]
[6.528933525085449, 9.548030853271484, "@SecretDiary Thanks Secret Diary, which herb do I use to treat hepatosplenic T-cell lymphoma?"]
[9.588318824768066, 7.936330795288086, "@JohnWAyersPhD @EdKrassen Yes I am all knowing"]
[10.383532524108887, 10.416158676147461, "Come see us at #ASH23 and meet the editors of the image bank and get some cool heme flash cards.  We\u2019re gonna have an image challenge competition. No one will beat me.  Not even @DavidSteensma https://t.co/rRHbgn5598"]
[8.176627159118652, 10.19711685180664, "@EdKrassen I know the answer.  Prior to being born you were not alive for an infinite amount of time.  It wasn\u2019t so bad.   That\u2019s what death is."]
[7.366340160369873, 10.85242748260498, "@BiggestComeback I do the keto as it works but at least for me it def sucks compared to eating carbs.  I do it because it works."]
[8.628580093383789, 9.232298851013184, "@VPrasadMDMPH Beyond crazy. Also this behavior is encouraged by NEJM because they published it"]
[7.139866352081299, 11.74119758605957, "@Persian1010 Read about the patients enrolled on that trial. Are they like the patients you are now treating?"]
[7.409117698669434, 12.15994644165039, "I have strong opinions on FLT3i maintenance post allo.  Basically we just put a patient through the most intensive therapy possible (induction chemo followed by an allogeneic transplant).  I will not prescribe maintenance unless I am given solid data of OS advantage. https://t.co/GeURmE8gzu"]
[8.743856430053711, 7.8470306396484375, "@WolverHeme @ajperissinotti @Berninini saving this for my run tomorrow after rounds!"]
[8.911213874816895, 10.336002349853516, "Nothing like reading a super long note from a consultant and at the end see the recommendation \"no new recommendations\""]
[9.044709205627441, 7.469123840332031, "@drkomanduri @sghmd I meant to add \u201cin San Diego or some place where it doesn\u2019t snow\u201d"]
[9.432246208190918, 9.370864868164062, "RT @sghmd: The typical academic molds should be broken and re-envisioned in the modern era.  It's time."]
[10.819961547851562, 11.901246070861816, "Thank you again nephrology for reminding me to avoid nephrotoxins in a patient with renal failure I consulted you on.\n\nPulmonologist should end all their notes \"avoid cigarettes\""]
[9.629340171813965, 8.062231063842773, "@liamgallagher Did Noel walk into the room?"]
[10.730765342712402, 12.152164459228516, "4 important flow cytometry patterns for hematology boards!\n\nAPL = CD33+,CD117+, CD34-,HLADR-\nCLL = CD5+, CD19+,CD20dim+, CD23+\nMCL = CD5+, CD19+, CD20+, CD23-, FMC7+\nHCL = CD11c+, CD19+, CD20+, CD25+, CD103+, CD123+\n\nRemember key differences!\nCLL CD5+, CD23+ but  MCL CD5+ CD23-!"]
[5.658924579620361, 11.512206077575684, "RT @ManniMD1: Bispecifics in the real-world: What do we know so far, and what lessons can we learn? \n\nAn educational thread compiling all t\u2026"]
[9.59093952178955, 7.776676177978516, "@ManniMD1 @jo_waldschmidt @RascheLeo Such a game changer"]
[8.029623985290527, 11.867511749267578, "@rajshekharucms But we\u2019re more patients MRD negative???"]
[8.121848106384277, 9.946259498596191, "RT @marklewismd: All oncologists engage in lifelong learning; if we didn\u2019t, it would be malpractice, given the pace of the field\u2019s evolutio\u2026"]
[8.863161087036133, 7.621102333068848, "@MaxKonigMD Oscars. Pacific beach. You will thank me later"]
[9.846714973449707, 10.74515151977539, "Able to escape work for a nice San Diego evening at local beach. Any trainees should apply to our wonderful training programs in the greatest city in the USA. https://t.co/rtMvXrMQcB"]
[8.59290885925293, 8.680233001708984, "It\u2019s an honor to name this #USMIRC Award \u201cthe Mikael Ryaan Award \ud83e\udd47\u201d! it will be always a distinguished award #MedTwitter #MedEd #mmsm #myeloma https://t.co/KrHcHmhVm6"]
[8.896137237548828, 8.431708335876465, "@mumairmushtaq Congratulations \ud83c\udf89 brother well deserved"]
[9.379070281982422, 9.36974048614502, "RT @hamzahashmi87: Proud mentor moment: Congrats to @wwesson24, #superstar Med student from @KUcancercenter for his #ASH23 abstract achieve\u2026"]
[9.984442710876465, 9.497340202331543, "RT @hamzahashmi87: Proud mentor moment: Congrats to @DimaDanai for her oral presentation on RWE of Tec in RRMM at #Ash23 and winning and AS\u2026"]
[10.388589859008789, 7.825046062469482, "RT @thisisJamesD: https://t.co/iEa7FxADAe"]
[10.125189781188965, 9.810407638549805, "RT @thisisJamesD: #ASH23 abstracts are out today and I\u2019m super excited to be a part of 1 oral and 11 posters. A huge congrats to @DimaDanai\u2026"]
[8.246881484985352, 10.55496883392334, "Please follow the @OncoAlert Newsletter #MedTwitter #MedEd https://t.co/fZj4hpF6Y2"]
[8.700265884399414, 8.635393142700195, "Congratulations \ud83c\udf89\ud83c\udf8a\ud83c\udf88 for the #USMIRC group on the Awards and the achievements they earned this year 2023 including #ASH23 awards! @DimaDanai @wwesson24 @hamzahashmi87 @NausheenAhmedMD @AtrashShebli #MedTwitter #MedEd #mmsm #myeloma https://t.co/SRLgllBQeh"]
[8.282984733581543, 12.717939376831055, "DPd Vs DKd in RRMM in a retrospective study: https://t.co/fps202SO1S #mmsm #myeloma #MedTwitter #MedEd @OncoAlert @thisisJamesD @Rawana_97 @DimaDanai @NausheenAhmedMD #USMIRC #ASH23 https://t.co/bfYCxvg4Q8"]
[9.048208236694336, 13.2411527633667, "Global Access to Multiple Myeloma Medications (GLAMM-2 Study): Access &amp; Barriers to Chemoimmunotherapies &amp; Transplant worldwide https://t.co/08cRofbwXn ?ACCESS DENIED ? @OncoAlert #ASH23 @smbenlazar @nihardesai7 @hiragss @strouse_chris @DrRakeshPopat @kczmj @NausheenAhmedMD\u2026 https://t.co/F72cECoSoz https://t.co/blMGSYkD5n"]
[8.286118507385254, 13.351245880126953, "RT @NausheenAhmedMD: #ASH23 #access to #bispecifics and #CART in #myeloma across the globe.  Results of GLAMM-1 survey presented by #USMIRC\u2026"]
[7.580977439880371, 13.550593376159668, "Daratumumab-Based Regimens in Anti-CD38 Treatment-Na\u00c3\u00afve Relapsed/Refractory Multiple Myeloma with High-Risk Cytogenetics\nOS in 2+ HRCyto RRMM 22.5 months! @j_snyder0132 @hhashmi87 @AimazAfrough @AtrashShebli @mumairmushtaq @NausheenAhmedMD #USMIRC #mmsm #myeloma #MedTwitter\u2026 https://t.co/hXi5MqqTI6 https://t.co/th6V4EeRfX"]
[6.977628707885742, 11.79434585571289, "Outstanding work by the team @DimaDanai @thisisJamesD @hhashmi87 #USMIRC Using Teclistimab in RW (55% were refractory to BDT): ORR was 64% for the entire cohort; ORR was 57%, 66% and 45% for patients who were BDT-refractory, penta-refractory, or had EMD, respectively @hiragss\u2026 https://t.co/5UUMgUUGDG https://t.co/2lT2kq4XsK"]
[8.068921089172363, 13.400360107421875, "RT @NausheenAhmedMD: Discover the safety of #BCMA #CAR-T in multiple myeloma #allotransplant recipients. Case series focusing on CRS/ICANS/\u2026"]
[10.95526123046875, 8.374526977539062, "https://t.co/G4Yt7GChra"]
[8.914151191711426, 13.181931495666504, "GLAMM1 Study - Global Access to Myeloma Medications: Potential Barriers to CART and TCE Globally by #USMIRC group @Rawana_97 @mumairmushtaq @smbenlazar @nihardesai7 @thiagoxcarneiro @DrRakeshPopat @AtrashShebli @kczmj @NausheenAhmedMD $$$ is the cause of these barriers!\u2026 https://t.co/bAcXDf0BTI https://t.co/cKxqEueV90"]
[8.306390762329102, 10.511435508728027, "Follow Newsletter from @OncoAlert #MedTwitter #MedEd https://t.co/7plgfEsH97"]
[9.354416847229004, 10.651066780090332, "1st Multidisciplinary Amyloid Symposium in Kansas on 12/2/2023! Colleagues from Heme/Onc, Cardiology, Neurology and Nephrology are welcome for registration #mmsm #Cardiology #cardioOncology #MedTwitter #MedEd @KUHospitalNews @KUcancercenter @KUHospital @KUMedCenter #USMIRC https://t.co/RIOOjaVNY5"]
[11.020967483520508, 8.388654708862305, "https://t.co/HCnTiVkSUy"]
[7.25212287902832, 12.093499183654785, "Outcomes of Pts with RRMM who received \u2265 2 BDT therapies:  PFS for 1st BDT was 5.8 months, while for 2nd BDT it was 5.2 months. Median OS from exposure to 1st BDT was 19.5 months #USMIRC #ASH23 @j_snyder0132 @NausheenAhmedMD @AtrashShebli @kczmj @OncoAlert #medtwitter #MedEd\u2026 https://t.co/0RGBpkni3e https://t.co/Rrv8ZPp8sm"]
[9.332585334777832, 7.9488701820373535, "Hat-rick! \u26bd\ufe0f finally"]
[8.802109718322754, 10.93636417388916, "Some parasites turn hosts into \u2018zombies\u2019\nParasitic infections are extremely common, but not likely to cause zombie apocalypse\nhttps://t.co/dEDmqBNqwK"]
[9.619477272033691, 8.646116256713867, "Join @NehaMehtaShahMD from @WashUOnc @WUDeptMedicine  @SitemanCenter #nhlsm \n@WUHemeOncFellow @HemOncFellows https://t.co/CD2NXN8c9x"]
[9.830629348754883, 11.435754776000977, "The American Heart Association (AHA) has now formally voted to join several other cardiovascular societies to form a new professional certification board for cardiovascular medicine, to be known as the American Board of Cardiovascular Medicine (ABCVM).\n\nThe ABCVM would be\u2026 https://t.co/Rm4CrlBxfN"]
[9.526869773864746, 8.901668548583984, "RT @WashUOnc: Fantastic work from another great @WUSTLmed collaboration: @WashUOnc @WashUSurgery @GenomeInstitute @SitemanCenter @WUSTL_ENT\u2026"]
[9.139484405517578, 12.621894836425781, "RT @VincentRK: Kudos to the International Myeloma Society (IMS) for sending a survey to its members on ABIM MOC. Please participate! \n\n@Mye\u2026"]
[10.119302749633789, 11.504091262817383, "Maybe it is time for a new petition @AaronGoodman33\n\nCan we get @ASH_hematology @ASCO @ASTCT to form a new hematology/oncology certification group separate from ABIM/MOC similar to the cardiology approach?  RT or respond if you agree\n\nhttps://t.co/OIR5Kss38B"]
[8.300337791442871, 8.309922218322754, "RT @DavidSteensma: An article I wrote on the history of stamp/philatelic vignettes @JAMA_current &amp; @MayoProceedings and Bob Kyle's contribu\u2026"]
[10.9568452835083, 8.3909912109375, "Interesting concept. https://t.co/TYkrhqEcmi"]
[9.978161811828613, 8.742013931274414, "At the pink concert have to say this was amazing! https://t.co/eofQZgL6x8"]
[8.027393341064453, 9.11732292175293, "A lot of people suffering to raise money for charity - respect. https://t.co/S6NJMeMhBC"]
[6.773260116577148, 11.200662612915039, "At the Miami Translational research meeting a tour de force talk on WGS and resistance to immunotherapy from Dr Maura. https://t.co/V7rzrO4cGY"]
[7.707927227020264, 14.287190437316895, "RT @FrancescoMaura4: Excited to share our new paper entitled \u201cImpact of rare structural variant events in newly diagnosed multiple myeloma\u201d\u2026"]
[9.41227912902832, 9.167703628540039, "RT @NBahlis: Excited to see this seminal work published today @BCD_AACR led by the talented Paola Neri and @BioBenBarwick on Transcriptiona\u2026"]
[8.62695598602295, 10.097236633300781, "Had great fun working on this and think it tells a great and clinically useful story.@DrOlaLandgren @EileenMBoyle @FrancescoMaura4 https://t.co/5Xn24LCOUr"]
[10.27159595489502, 11.303725242614746, "This 3-year program will begin in Q1 of 2024. If you are interested in this NEW opportunity, send us a DM!\n\nCome join us in beautiful Miami!\n\n(10/10)\n\n#mmsm @theMMRF @IMFmyeloma @ASH_hematology @HealthtreeMM @LLSusa @SylvesterCancer @univmiami #miami #NYC #boston #sanfrancisco https://t.co/oYAT0U3TzX"]
[9.065113067626953, 13.694091796875, "Together, we aim to decipher the intricate data landscape and triumph over multiple myeloma. Sponsors/Mentors at each site consist of (i) a \u200bcomputational \u200boncology \u200bexpert and (ii) a translational \u200bmedicine expert in multiple myeloma \n\n(9/X)"]
[9.229833602905273, 9.588674545288086, "In addition to their primary projects at their respective institutions, fellows/post-docs will meet regularly in cross-institutional collaboration with fellows/post-docs at other participating sites (UM, NYU, MDACC), potentially developing collaborative projects\n\n(8/X)"]
[9.286520004272461, 13.841800689697266, "Currently, MSF has funded three computational oncology fellowship/post-doc positions: one at University of Miami (UM), one at New York University (NYU) and one at MD Anderson Cancer Center (MDACC). Additional site may be added in the future\n\n(7/X)"]
[9.130488395690918, 13.846551895141602, "This NEW computational oncology fellowship/post-doc is a 3-year program which will begin in Q1 of 2024; it is positioned at the intersection of computational science and oncology. \n\nIt is supported by a generous grant from the Myeloma Solutions Fund (MSF)\n\n(6/X)"]
[8.85423469543457, 14.004682540893555, "Our fellows/post-docs will have the opportunity to develop and utilize cutting-edge computational models to predict disease progression, treatment responses, and outcomes for individuals with high-risk multiple myeloma, with an emphasis on the t(4;14) subtype\n\n(5/X) https://t.co/XBpwP6xb00"]
[9.259082794189453, 13.803133964538574, "This wealth of data not only enhances our knowledge of the disease biology but also poses new scientific &amp; logistical challenges. To tackle this complexity and develop personalized strategies, collaboration, large datasets, &amp; advanced computational approaches are vital\n\n(4/X) https://t.co/2f1anQewDu"]
[8.69676685333252, 14.044625282287598, "Next-generation sequencing has revolutionized our understanding of the myeloma genome, providing unparalleled resolution that has unveiled a complex and heterogeneous architecture that can significantly impact clinical outcomes.\n\n(3/X)"]
[9.258967399597168, 13.791826248168945, "We seek to generate innovative computational models that can help predict disease progression, treatment outcomes, or patient response. Also we will foster interdisciplinary collaboration between computational scientists and translational scientists\n\n(2/X) https://t.co/iUFSM7Hq3t"]
[8.999862670898438, 13.8011474609375, "We are launching a NEW COMPUTATIONAL ONCOLOGY FELLOWSHIP/POST-DOC program at University of Miami! \n\nThis NEW position has been created to accelerate research on high-risk myeloma with emphasis on the t(4;14) subtype\n\nIf you are interested in this opportunity, send us a DM!\n\n(1/X) https://t.co/DoWZucFjp3"]
[10.612064361572266, 11.644608497619629, "See you soon at #ASH23 in San Diego!\n\n@theMMRF @IMFmyeloma @HealthtreeMM @LLSusa @ASH_hematology @SylvesterCancer @univmiami #mmsm #miami @NIH @theNCI @JanssenUS @pfizer @bmsnews @SanofiUS @Amgen @Karyopharm @abbvie @TakedaOncology @genentech @Regeneron https://t.co/4KiddieYTN"]
[6.875720500946045, 12.856534004211426, "Dr Saemundur Rognvaldsson @SaemundurMD will present data on monoclonal gammopathy of undetermined significance and the risk of thrombotic events: results from iStopMM, a population-based screening study in Iceland\nhttps://t.co/HeX1otIU7F\n\n@sykristinsson #mmsm #ASH23"]
[6.5905961990356445, 12.694523811340332, "Dr Thorir Einarsson Long will present a revised definition of free light-chains in serum and light-chain monoclonal gammopathy of undetermined significance: results of the iStopMM study\nhttps://t.co/1fncmQLeF6\n\n@sykristinsson #mmsm #ASH23"]
[6.716620445251465, 12.794512748718262, "Dr Saemundur Rognvaldsson @SaemundurMD  will present data on the early benefits and psychological effects of screening for monoclonal gammopathy of undetermined significance: results of the iStopMM study\nhttps://t.co/PcjvDO30R0\n\n@sykristinsson #mmsm #ASH23"]
[7.543130397796631, 13.951326370239258, "Dr Marcella Kaddoura will present on the temporal evolution of chromosome 1q gain and hyperdiploidy and its impact on clinical outcomes in multiple myeloma\nhttps://t.co/1XQaglB125\n\n@francescomaura4 #mmsm #ASH23"]
[7.708101749420166, 14.308793067932129, "Dr Anthony Cirrincione @cirriant will present data revealing novel mechanisms underlying inactivation of tumor suppressor genes on duplicated chromosomes in multiple myeloma\nhttps://t.co/BwVelNHC7U\n\n@francescomaura4 #mmsm #ASH23"]
[7.631449222564697, 14.18432903289795, "Dr Marios Papadimitriou will present on the genomic and transcriptomic landscape of hyper-APOBEC multiple myeloma\nhttps://t.co/3RsEigM8tl\n\n@francescomaura4 #mmsm #ASH23"]
[8.250700950622559, 13.714652061462402, "Dr Ben Diamond @BenDiamondMD will present on genomic profiling to interpret the outcomes of early intervention for high-risk smoldering myeloma\nhttps://t.co/5UJLpIcBt2\n\n@dikokaz #mmsm #ASH23"]
[7.4391398429870605, 13.427042007446289, "@DrOlaLandgren will present long-term followup data from the daratumumab monotherapy Phase 2 Centaurus study\nhttps://t.co/U89zhplp9Q\n\n@EagleMyeloma #mmsm #ASH23"]
[8.16503620147705, 13.694719314575195, "Dr Elizabeth Hill from @NCI will present long-term followup data from NCI's original trial for smoldering myeloma patients, using KRd followed by 2 years of lenalidomide maintenance https://t.co/8izJrlTEX1\n\n@dikokaz #mmsm #ASH23"]
[9.172871589660645, 13.22000789642334, "At #ASH23 in San Diego in Dec 2023, the Myeloma Institute at Univ of Miami will give several oral presentations and participate in many collaborative myeloma talks. \nCongrats to everybody who has contributed. Here is a list of presenters and topics, as well as links to abstract: https://t.co/OL3OfmDVZP"]
[10.021164894104004, 10.702985763549805, "This 3-year program will begin in Q1 of 2024. \n\nIf you are interested in this NEW opportunity, send us a DM! \n\nCome join us in beautiful Miami! \n\n(8/8) https://t.co/Y73EOOHo0h"]
[9.089247703552246, 13.731042861938477, "Together, we aim to decipher the intricate data landscape and triumph over multiple myeloma. \n\nSponsors/Mentors consist of (i) a \u200bcomputational \u200boncology \u200bexpert and (ii) a translational \u200bmedicine expert in multiple myeloma.\n\n(7/X)"]
[8.959113121032715, 8.441875457763672, "@MalinHultcrantz @FredsTeam @MSKCancerCenter Great congrats, Malin! Awesome accomplishment!"]
[8.942347526550293, 8.415711402893066, "@DrMvandenBrink @DKMS_us @DKMS_de Great congrats, Marcel! Outstanding achievement!"]
[8.231956481933594, 13.107526779174805, "RT @MedscapeLIVE: \ud83d\udea8 DON'T MISS: Experts @DrOlaLandgren, @End_myeloma, and Nisha S. Joseph, MD present \ud83d\udcc8 emerging therapies for #MM and impl\u2026"]
[7.805516719818115, 9.502097129821777, "RT @VivekSubbiah: \u2b50\ufe0fSo honored to be invited to deliver the 1st lecture at the 1st ever Miami Translational &amp; Clinical Oncology #TCO Sympos\u2026"]
[7.735074043273926, 14.259786605834961, "RT @FrancescoMaura4: Excited to share our new paper entitled \u201cImpact of rare structural variant events in newly diagnosed multiple myeloma\u201d\u2026"]
[7.746452808380127, 9.558293342590332, "RT @VivekSubbiah: \u2b50\ufe0f 1st ever Miami Translational &amp; Clinical Oncology #TCO Symposium Sylvester Comprehensive Cancer Center \n\ud83d\udc49\ud83c\udffcWow, what an\u2026"]
[10.74710750579834, 10.969852447509766, "Fun Friday at ASH. Please join us! https://t.co/jvuhsskASm"]
[9.197461128234863, 10.02336311340332, "Refreshing to see an academic collaboration trial providing \"ready to use\" , context-relevant results getting stage time at #ASH23 https://t.co/4pOJXubFOg"]
[8.829157829284668, 13.400092124938965, "RT @My_Cancer_Haven: Save the Date: November 11th, 2023\nPatterns of Practice in Relapsed Multiple Myeloma:\nA MyCancerHaven Webinar.\nFor mor\u2026"]
[10.121973991394043, 10.338322639465332, "RT @ESHaematology: #ESHMM2024 DID YOU SAVE THE DATE?\n\u27a1October 4-6, 2024: mark you agenda &amp; join us in Mandelieu-La Napoule, France \ud83c\uddeb\ud83c\uddf7 for t\u2026"]
[9.324809074401855, 13.13780403137207, "Putting together a section of a talk about the history of myeloma.    Thinking of the title \u201csee Kyle\u201d.  To anyone looking to begin to understand where we have come from in this disease. Go to pubmed.. type \u201cRobert Kyle and Myeloma\u201d and read !    #mmsm \u2066@VincentRK\u2069 https://t.co/3MViSl2Zpq"]
[8.611932754516602, 12.49976921081543, "RT @mtmdphd: 2022 Myeloma / Plasma Cell Dyscrasia ~ #ASH22Top10 (or so) #mmsm #mmMRD #ASH22 - @mtmdphd *DRAFT* Table Update: Dec 10, 2022 v\u2026"]
[10.333531379699707, 7.865306377410889, "RT @bdermanmd: One of those days... https://t.co/RfQymjrgly"]
[6.767367839813232, 11.458137512207031, "RT @RahulBanerjeeMD: I\u2019ve definitely lost some of my enthusiasm for frontline Cy in #MMsm based on \ud83c\uddeb\ud83c\uddf7 Bridoux CyBorD vs Vd trial, but this\u2026"]
[9.077095985412598, 13.693100929260254, "RT @TischCancer: Mount Sinai Researchers Receive $7 Million to Improve Outcomes for High-risk Blood Cancer Patients From the Multiple Myelo\u2026"]
[9.219515800476074, 12.191021919250488, "@Rfonsi1 @DrKrinaPatel @Ccostello7 @HealthTree @AhlstromJenny @MyelomaTeacher @ASU @michaelcrow Such an amazing group of docs.    I have intense FoMMo.    Fear of missing out on an amazing myeloma event"]
[6.718072414398193, 11.263062477111816, "RT @TheLancetHaem: \"With the emergence of highly effective clone-directed therapies, where does HDM-AHCT fit in the treatment framework of\u2026"]
[10.080004692077637, 10.406907081604004, "RT @COMyCongress: \ud83d\udce2We are excited to announce the dates for our\nnext COMy Congress \nMay 23-26, 2024 \nParis &amp; Online\n\n\u2728This is a very specia\u2026"]
[8.769355773925781, 13.428135871887207, "RT @My_Cancer_Haven: Save the Date: November 11th, 2023\nPatterns of Practice in Relapsed Multiple Myeloma:\nA MyCancerHaven Webinar.\nFor mor\u2026"]
[9.160012245178223, 9.93044376373291, "RT @Mohty_EBMT: Peer-review is a pillar of scientific research. Thank you @JCO_ASCO for kindly acknowledging the dedication of reviewers. @\u2026"]
[8.712471008300781, 9.543947219848633, "The goal is cure !    Words to live by from Dr Sundar Jagannath who is being honored today the CFS meeting.    An inspiration to all of us.  #mmsm \u2066@TischCancer\u2069 \u2066@MountSinaiNYC\u2069 https://t.co/zf5PAgOckX"]
[7.86216402053833, 11.244956016540527, "RT @EWidera: It's a tale as old as Pharma time: Step 1: lower thresholds used to diagnose disease. Step 2: Support the writing of articles\u2026"]
[6.783792972564697, 10.084975242614746, "@DrAaronThomason @esinghimd @MDAndersonNews @OncoAlert @LUNGevity @EGFRResisters @KRASKickers @ALKpositiveINT @BrafBombers @OncBrothers @LungCancerFaces @metcrusaders @RetRenegades So I don\u2019t know if I agree with you that early screening is the number 1 to beat lung cancer. Sounds nice but data doesn\u2019t hold up."]
[6.68618631362915, 10.168017387390137, "@DrAaronThomason @esinghimd @MDAndersonNews @OncoAlert @LUNGevity @EGFRResisters @KRASKickers @ALKpositiveINT @BrafBombers @OncBrothers @LungCancerFaces @metcrusaders @RetRenegades https://t.co/UCWwGULj28\n\nNuance needed when talking about early detection- it\u2019s shown in this study from South Korea what widespread roll out of CT scan led to 6 fold increase in rates of early lung cancer, but virtually 0\ufe0f\u20e3 change in late stage lung CA."]
[7.839898586273193, 9.770050048828125, "RT @SuyogCancer: Dr Booth speaking about time toxicity in cancer care  and what is essential and what is not for oncology practice.  Choosi\u2026"]
[9.220654487609863, 7.59110164642334, "@SuyogCancer @DrNikitaMehra @ecancer @SirohiBhawna Having so much FOMO! Amol- hopefully will get to meet you too, someday!"]
[9.55954360961914, 12.431015968322754, "RT @SuyogCancer: Choosing wisely for hemato lymphoid cancers in India . Great talk by  @DrNikitaMehra . \nChoosing wisely meeting at Mumbai\u2026"]
[8.255890846252441, 13.964707374572754, "RT @eClinicalMed: Clinician preferences on treatment of smoldering myeloma: a cross-sectional survey\n\nActive surveillance is the prevailing\u2026"]
[10.47398853302002, 11.685027122497559, "@laura_korin @ASH_hematology @Grupo_GELL I hope we can do the same for South Asia @DrNikitaMehra \ud83d\ude0a"]
[9.648541450500488, 8.323623657226562, "@SerottaA @fatoki09 Will have to explain in person! Great points/questions."]
[5.682353496551514, 11.4738130569458, "We have many debates on CAR versus bispecifics.\n\nBut for those who desperately imminently need therapy now for progressions- bispecifics beat CAR out of the park, IMO."]
[5.982794284820557, 11.537973403930664, "Everyday in my clinic there is selection bias in favor of \u2b06\ufe0f PFS for CAR-T.\n\nAggressive disease, rapidly rising light chains: Give bispecifics \n\nIndolent progressions, planning for next tx in advance: Think CAR.\n\nCilta-cel real world PFS will be stellar for this reason, IMO"]
[5.811594009399414, 11.800994873046875, "@DrPaulyDeSantis If MAICs are the way to go.\n\nThen cilta-cel is better than ide-cel\n\nBut elra also better than tec \ud83d\ude02"]
[9.68265438079834, 8.077048301696777, "@nihardesai7 What about cricket, bro?!"]
[7.400786399841309, 11.615447044372559, "@AdiG1993 I guess reasonable people can argue whether or not treatment is needed for these patients. \n\nI (and the majority of clinicians) dont think treatment is needed- but others may disagree?\n\nhttps://t.co/Iei8NhTSmt"]
[6.857633113861084, 11.955381393432617, "@AdiG1993 To be fair, I don\u2019t think so. It\u2019s an ethically done clinical trial under IRB regulations with appropriate consent. \n\n I find small trials like this that test already active drugs to be uninformative (and maybe net harm to enrolled pts)- but don\u2019t think it\u2019s criminal/unethical."]
[5.762831687927246, 11.71850299835205, "Or it may be that Janssen did it- and showed that elra was better, and then decided to bury the project.\n\nWhich is why MAIC's are so problematic. \n\nYet to find one that has results that go against what the sponsor wanted to find."]
[6.103437423706055, 11.955785751342773, "Another matched indirect comparison to answer a definitive question \ud83d\ude09\n\nElranatamab is better than teclistamab.\n\nI am curious to see the same study done by Janssen that may show teclistamab is better, by changing some of the methods.\n\nhttps://t.co/LY39hrXxtg\n\n#ASH23 #mmsm https://t.co/8dDxlsYyqa https://t.co/taUNKH5Eou"]
[6.761674880981445, 11.917695999145508, "Excellent use of real-world data\n\nConfirms previous smaller data fairly conclusively\n\nn=2,522, 36.8% twice a week bortezomib, 63.2% once week\n\nNo difference in efficacy outcomes (even though high-risk was more likely to be given twice week)\n\nhttps://t.co/g3G5tmGOum\n\n#mmsm #ASH23 https://t.co/PW74r8q1EM"]
[7.86991548538208, 12.283299446105957, "Important real-world data of dara/len/dex (DRd) vs VRd\n\nhttps://t.co/ufTaBnMoBO\n\nMost important finding (confirming what I see in clinic) is that real world mileage with DRd isnt 60 mo of PFS.\n\nOnly 60% still on DRd at 2 yrs of follow-up(time to next treatment)\n\n#ASH23\n#mmsm https://t.co/WBTm8gqOJU https://t.co/Pex7v3bwoR"]
[5.8745646476745605, 11.86294174194336, "That said and done- even though we shouldn\u2019t cross-compare trials, I probably would want cilta-cel for myself or family over ide-cel, if I was in that situation."]
[7.142911434173584, 11.778368949890137, "@hemotrasplantuc And also, not all these patients are high-risk. \n\nUsing the PANGEA scoring system, a lot of these patients have a fairly low risk of progression (20% ish) in the next few years, but still would qualify for this trial."]
[7.6962738037109375, 11.977163314819336, "@hemotrasplantuc That\u2019s a great Q absolutely worth studying. But the data so far indicates that these patients aren\u2019t being cured. \n\nFor example- in long-term follow up of pts with SMM treated with KRd&gt;auto&gt;KRd&gt;len maintenance, only 23% of pts sustained MRD neg 4 years post auto transplant :("]
[5.847365379333496, 11.810041427612305, "After this matched adjusted analysis run by Janssen (the maker of cilta-cel), I am now fully convinced that cilta-cel is better than ide-cel. \n\nJust what I needed to convince me. \n\n\ud83e\udd23\n\nhttps://t.co/bvQHPB9lfw\n\n#ASH23"]
[10.970839500427246, 8.331336975097656, "https://t.co/rdciJnnQ9w"]
[6.338623523712158, 12.075916290283203, "Describing this trial of teclistamab in smoldering MM to pts:\ud83d\ude1f\n\nYou may not need treatment for yrs. When you do need tx, you are likely to live for decades. \n\nBut we could treat you now with teclistamab- where 1/12 pt got Gr3 pancreatitis, 1/12 got uveitis, and 9/12 got infxns https://t.co/nUOT6nVOzW"]
[6.505299091339111, 12.696208953857422, "@Peperom36001888 @iStopMM Free light chain ratio more than 3.15\n\nLikely to find monoclonal cells\n\nLess than 3.15\n\nUnlikely to find monoclonal cells\n\nSorry if I messed it up."]
[8.67061996459961, 9.005193710327148, "RT @rajshekharucms: @DrNikitaMehra @CancerGridIndia @csoncol Indeed, @VPrasadMDMPH has played a pivotal role in bringing critical appraisal\u2026"]
[8.045042991638184, 9.54608154296875, "RT @DrNikitaMehra: During the Choosing Wisely @CancerGridIndia @csoncol conference held at Tata Memorial Centre, Mumbai, Prof. Kumar Prabha\u2026"]
[7.027798652648926, 12.590593338012695, "@bbehin I don\u2019t think so. Current models for predicting SMM are wildly inaccurate and discordant. Some folks with SMM may never progress. Some will take years to progress- and we will have much better treatment options to treat them at that time."]
[8.274491310119629, 11.917373657226562, "@rabonour1 Most real world data very flawed.\n\nThis is more \u201creal-world\u201d than single center 20 person study though :)"]
[10.480186462402344, 7.876716136932373, "@iStopMM Link:\n\nhttps://t.co/pbwwqdpUAN"]
[6.529987335205078, 12.70496940612793, "Kudos to @iStopMM \n\n\u2b50\ufe0fEVAL OF LIGHT CHAIN MGUS\n\nA free light chain ratio of less than 3.15 has 92% sensitivity, 100% specificity for predicting PRESENCE of monoclonal plasma cells in bone marrow.\n\nIf FLC ratio less than 3.15- reassure and omit bone marrow biopsy!!\n\n#ASH23 #mmsm https://t.co/0iwDa7z26H https://t.co/CUWFJUMh59"]
[8.810483932495117, 11.113396644592285, "RT @VPrasadMDMPH: Great poll here. @AaronGoodman33 Sunny Kim and I explain why we should NOT treat in blood. Also the cooperative group did\u2026"]
[8.633169174194336, 14.171022415161133, "@CoachBon @bdermanmd @rajshekharucms @Eddie_Cliff Diffusion weighted MRI essential part of the conversation here- if no focal lesions or diffuse involvement- more comfortable watching.\nAmount of paraprotein in the urine also integral in decision making- has been shown to predict risk of CRAB in those with MM based on FLC ratio"]
[6.718761444091797, 12.515521049499512, "@CoachBon @bdermanmd @rajshekharucms @Eddie_Cliff I have observed a few patients who have high risk SMM including multiple high-risk CA, but their light chains have either increased very slowly or stayed stable/fluctuated over the time period observed. \n\nIf consistently rising light chain- recommend MM type treatment."]
[6.532751560211182, 12.463650703430176, "@CoachBon @bdermanmd @rajshekharucms @Eddie_Cliff Hard to give individual advice here. If light chains are consistent rising, and SLiM criteria already met, I would probably recommend treatment sooner rather than later. \n\nI offer/recommend observation to those with SLiM criteria but otherwise stable labs.\n\nCan DM me if needed."]
[9.33785629272461, 8.204459190368652, "@nihardesai7 Bro, this is how we know without a doubt that you\u2019re famous \ud83d\ude02"]
[8.135594367980957, 10.867526054382324, "RT @anish_koka: @altcap @theallinpod Cardiologist \ud83d\ude4b\ud83c\udffd\u200d\u2642\ufe0f\n\nTrue story.. \n\nLate 50s with no symptoms, father with triple bypass at 55.  Very i\u2026"]
[7.346298694610596, 12.867146492004395, "@AJPortuguese Definitely worth asking/discussing when this is presented.\n\nFor any new pt I see, I don\u2019t have tools that will tell how many yrs ago gain1q was acquired, and it won\u2019t change management either. This helps deepen my understanding, but as of now doesn\u2019t have direct clinical impact"]
[7.750546932220459, 13.01429271697998, "@FrancescoMaura4 @HDMyeloma @SylvesterCancer @MSKCancerCenter @univmiami Look forward to meeting at ASH.\n\nWould love to talk more about prognostic implications of gain1q when present in setting of other hyperdiploidies and no other high risk features. \n\nI don\u2019t generally consider this a high risk feature in that setting:\n\nhttps://t.co/yKE8mPdzkP"]
[7.640798091888428, 13.005949974060059, "\u2b50\ufe0fAlso reinforces that IgH translocation if present is the driver event and precedes everything else\n\u2b50\ufe0fperhaps the timing of when 1q happened (years before diagnosis or decades before diag?) may matter more than the copy number\u2753\n\nLink to abstract:\nhttps://t.co/uodFcaDKNo"]
[7.754563808441162, 13.217331886291504, "Great work on intersection of hyperdiploidies and translocations in myeloma\n\n\u2b50\ufe0fThe first hyperdiploidy is acquired ~33 years before diag!\n\u2b50\ufe0fIn those with IgH translocations and gain1q, an early onset of gain1q has worse prognostic implications than late onset of 1q\n\n#mmsm\n#ASH23 https://t.co/YND9i7TM7Z"]
[8.420076370239258, 13.70207691192627, "@OncologyCompany @Eddie_Cliff @laura_korin I think the degree of uncertainty one is willing to accept varies based on the setting and trade-offs. \n\nNot from a mathematical or statistical standpoint- but a philosophical/clinical decision making standpoint.\n\nJust my opinion."]
[10.876418113708496, 8.56777572631836, "@laura_korin I wrote a thread related to this topic some while ago:\n\nhttps://t.co/Pyf4uofZZ4\n\nDoesn\u2019t fully answer your question, but some nuance there!"]
[9.534984588623047, 9.035144805908203, "@CharlesMilrod @DrNikitaMehra @Eddie_Cliff @laura_korin We published our work here:\n\nhttps://t.co/d2oYG2iAct"]
[8.301438331604004, 13.625998497009277, "@CharlesMilrod @DrNikitaMehra @Eddie_Cliff @laura_korin Great work- has many parallels with what we saw for myeloma- although in myeloma, association appeared stronger for relapsed disease.\n\nWould be nice to highlight duration of follow-up for each of the studies you used- so often insufficient follow-up plays a part."]
[10.509592056274414, 9.754764556884766, "Links to all the abstracts (may not be latest version, poster/presentation will have more updates):\n\nMohan:  https://t.co/SO0qgxKpgv\n\nDima: https://t.co/W9GpnRLqnG\n\nMidha:  https://t.co/ExW1ly36A8\n\nAsoori: https://t.co/7c9FpWM9GB"]
[6.212841510772705, 11.9674654006958, "So to summarize:\n\n1) In the real-world, teclistamab has comparable response rates.\n2) The duration of follow-up is far too short to make more meaningful conclusions regarding efficacy\n3) There is a selection bias as pts with really advanced/aggressive disease get bispecs.\n\nEND."]
[6.43385648727417, 11.832937240600586, "Until I have stronger data to suggest otherwise, I would view teclistamab and elranatamab like Coke and Pepsi.\n\nJust like daratumumab and isatuximab. \n\nMuch to learn regarding sequencing of BCMA therapies- I hope for more prospective data in this space."]
[5.726869583129883, 11.584136962890625, "That doesnt mean bispecifics are worse than CAR-T.\n\nThey just are more accessible to patients in need.\n\nAnd they are often used in desparate situations- as the above table shows.\n\nWould we expect similar results with elranatamab?"]
[6.179774761199951, 11.995244979858398, "I suspect that real-world performance of teclistamab will actually be poorer than the trial. And that is because of patient selection.\n\nWhereas real-world performance of cilta-cel may also be stellar. Again due to patient selection."]
[6.760761260986328, 12.164981842041016, "Such a short duration of follow-up will lead to an inaccurate PFS estimate.\n\nWith further follow-up, the PFS may be longer, or shorter than this estimate. It is hard to conclude much regarding PFS or durability of response with all these datasets currently."]
[6.259183883666992, 12.108400344848633, "Summarized in table.\n\nKey lessons:\n\n\u2b50\ufe0fPatients with advanced disease get teclistamab (more than 40% with extramedullary disease, 30-50% already received prior BCMA therapy)\n\u2b50\ufe0fThe duration of follow-up in all these studies is far too short (1-3 months!)\n\u2b50\ufe0fResponse rates similar https://t.co/3fdEHKAW3J"]
[8.880233764648438, 13.983529090881348, "We have 4 datasets with n&gt;50 using teclistamab\n\n1)@ShoMidha Dana Farber experience presented at #IMS23\n2) International Myeloma Foundation immunotherapy subgroup experience presented at #IMS23\n3) @MeeraMohanMD multi-center at #ASH23 \n4) @DimaDanai multi-center at #ASH23"]
[6.330451965332031, 12.095233917236328, "Lets first prime ourselves by recapping teclistamab trial data, published here:\n\nhttps://t.co/naBoZ4cv3u\n\nN=165,\nOverall response rate=63%\nMedian duration of response=18 months\nPFS= 11.3 months\nMedian prior lines=5\n77.6% triple refractory.\n\nPrior BCMA exposure not allowed. https://t.co/iSPsIGBmTm"]
[5.8089213371276855, 11.561171531677246, "In my clinical practice, patients with advanced/refractory MM with aggressive disease get bispecifics, whereas those with more indolent/slow relapses get cilta-cel.\n\nWhat this will lead to is a selection bias- with poor efficacy of bispecifics in real life compared to CAR-T"]
[8.267279624938965, 13.412893295288086, "Bispecifics in the real-world: What do we know so far, and what lessons can we learn? \n\nAn educational thread compiling all the real-world data we have for teclistamab in myeloma so far, including that presented at #ASH23. \n\n#mmsm\n\n\ud83e\uddf5\n\n1/"]
[9.592438697814941, 13.308442115783691, "@AaronGoodman33 No. You must do useless research and play the game. \n\nI can provide some ideas- there are some rare subsets of diseases where disparities haven\u2019t yet been shown using every single publicly available dataset\u2026 \ud83d\ude1c"]
[7.660152912139893, 10.259252548217773, "RT @VPrasadMDMPH: Just OUT! By @DavidBenjaminMD \nWe discuss evidence for STARTING &amp; STOPPING cancer drugs!\nWhat do I mean?  \nCurrently in c\u2026"]
[6.513654708862305, 12.517330169677734, "RT @AdeAdamson: I'm scratching my head because there is ZERO evidence supporting UV exposure associated with the development of keratinocyt\u2026"]
[9.583008766174316, 9.086824417114258, "@ClayReedMD I will try to compile thoughts, papers and recs on it! May take a bit, but will do."]
[8.975411415100098, 11.10019588470459, "@Amyloid_Planet @rajshekharucms Observation probably better in terms of quality of life here and likely equivalent for OS. \n\nIn pooled analysis of ixa versus placebo maintenance trials, patients had better survival on placebos."]
[7.142706871032715, 11.960956573486328, "RT @rajshekharucms: This trial serves as an important reminder for the fact that ixazomib should have NO role in post-transplant maintenanc\u2026"]
[10.629622459411621, 8.551595687866211, "I stand corrected- there is a fifth one too:\n\nhttps://t.co/XgrjhKOmhf https://t.co/i98U9vF1P0"]
[10.485450744628906, 9.61968994140625, "5 real-world teclistamab experiences (with n&gt;50) to date.\n\nMohan:  https://t.co/rK5Lg0TCcF\nDima: https://t.co/zD5TVV8SFl\nMidha:  https://t.co/mbcY4UOrpg\nAsoori: https://t.co/lGc17jTVwa\nRiedhammer: https://t.co/JvXiOlReHT\n\n#mmsm \n#ASH23 \n\n@jo_waldschmidt @RascheLeo https://t.co/fJs5yeaC7P"]
[9.292420387268066, 12.379927635192871, "RT @NBahlis: \u2066@MyelomaCanada\u2069 \u2066@akeithstewart\u2069 starting the annual Myeloma Canada  meeting in Montreal. Tour de force talk in high risk mye\u2026"]
[8.763952255249023, 10.050128936767578, "RT @JagSinghMD: So psyched to be presenting  on \u2018Rethinking and Reinventing Medicine\u2019 at South by Southwest 2024!  \n\nSee you guys in Austin\u2026"]
[9.650860786437988, 8.989628791809082, "RT @fredhutch: What happens when scientists take on a pumpkin carving challenge? @HutchBasicSci unleashes their creative genius! Happy Hall\u2026"]
[10.240283966064453, 8.005125045776367, "RT @hemedoc: @RahulBanerjeeMD @stephestern @LaurenThayerNP I did four years of Trump and I think we can all agree that four years was more\u2026"]
[8.780059814453125, 8.901633262634277, "@hemedoc @fredhutch @UCSF Haha you are too kind - I was the only attending who brought a Halloween costume to clinic today, but totally worth it!\n\nOne nurse asked if I was Left Shark from 2015, and the fact that I already had my MD by then and knew the reference is proof I\u2019m old enough for this job \ud83e\udd23"]
[9.807886123657227, 8.53200626373291, "RT @hemedoc: @RahulBanerjeeMD @fredhutch This photo is proof of your training @UCSF being complete! \ud83d\ude02 #welldoneyoungpadawan"]
[9.872625350952148, 7.670131683349609, "@hemedoc @stephestern @LaurenThayerNP Wonderful costumes as always!! I assume TFG being under a gag order in two separate court cases is why you had to retire his outfit \ud83d\ude09"]
[9.435966491699219, 10.285301208496094, "RT @hemedoc: Sharing some HUNNY with my stellar BMT coordinator, Stephanie Blitzstein, and leukemia NP, Lauren Thayer, without both of whom\u2026"]
[9.430051803588867, 12.643771171569824, "RT @UdayYanamandra: Indian Myeloma Academic Group @IndMyAcGp invites you all to register for the upcoming Indian Myeloma Congress 2024 in P\u2026"]
[8.457606315612793, 14.297924041748047, "RT @rajshekharucms: Amazing thread on WB DW-MRI by @MyMKaiser! IMO, we should almost never make a diagnosis of Smoldering Myeloma or Solita\u2026"]
[10.006465911865234, 8.225924491882324, "RT @fredhutch: @RahulBanerjeeMD AMAZING! \ud83d\udc4f\ud83d\udc4f\ud83d\udc4f\ud83c\udf83"]
[10.23961353302002, 7.850106239318848, "RT @drjgauthier: \ud83d\ude31\ud83d\ude31\ud83d\ude31"]
[9.863653182983398, 8.36731243133545, "RT @ROlinMD: Sunrise through the trees at Parnassus this morning. @UCSFCancer https://t.co/6C0tmTCBOJ"]
[11.030190467834473, 11.990726470947266, "@Ghoshomy @ASH_hematology By 2123, my sad guess is that will have to hold the #ASH23 meeting in Anchorage Alaska to find somewhere with moderate December weather\u2026 \ud83d\ude43\n\nSo we\u2019ll be able to tell from the location!"]
[10.47462272644043, 11.785135269165039, "RT @Ghoshomy: @RahulBanerjeeMD @ASH_hematology What do we do for 2123?"]
[10.206153869628906, 12.091980934143066, "@mtmdphd @mshadman @ASH_hematology @fredhutch @ASHClinicalNews @szusmani @Myeloma_Society Very much so! My guess is that the instinct to add a four-digit year must be a European thing? I\u2019ve always been fascinated by this!"]
[9.785209655761719, 12.35797119140625, "RT @mtmdphd: @RahulBanerjeeMD @mshadman @ASH_hematology @fredhutch @ASHClinicalNews @szusmani @Myeloma_Society Some of us have been saying\u2026"]
[10.52944564819336, 11.844964981079102, "RT @Bethfaiman: @RahulBanerjeeMD @ASH_hematology \ud83d\udc4f\ud83d\udc4f\ud83d\udc4f"]
[10.666463851928711, 11.447050094604492, "@DrNikitaMehra @ASH_hematology Yes indeed - looking forward to hanging out! San Diego beats LA any day of the year :)"]
[10.615621566772461, 11.625955581665039, "RT @DrNikitaMehra: @RahulBanerjeeMD @ASH_hematology See you at #ASH23 ! \ud83d\ude4c\ud83c\udffd"]
[10.840639114379883, 11.652176856994629, "Trying to move on this preemptively - only with all of your help can we finally have a unified hashtag for #ASH23!\n\nSee meme and official @ASH_hematology reply below:\n\nSee you all in San Diego! https://t.co/8utd4zXc3w https://t.co/Q9glUv41U6"]
[10.879473686218262, 12.047687530517578, "RT @ASH_hematology: See what's in store for #ASH23! View the abstracts selected now: https://t.co/0rBtyUOSqn\n\nExperience the science in San\u2026"]
[10.285735130310059, 11.899909019470215, "@mshadman @ASH_hematology @fredhutch @ASHClinicalNews Noooooo please stomp out the extra digits and go with #ASH23! Easier on thumbs, easier to stay under Twitter character limits, and I doubt anyone will confuse this with scientific meetings from 1923 \ud83d\ude09\n\nCc @szusmani who helped usher this change for @Myeloma_Society at #IMS23!"]
[7.987691879272461, 10.000432014465332, "RT @JAMANetworkOpen: Women and parents report greater burden from early AM/late PM multi-disciplinary tumor boards. Radiologists, pathologi\u2026"]
[7.952092170715332, 9.678672790527344, "RT @tanyawildes: \ud83d\ude0d\ud83d\ude0d\ud83d\ude0dthis study. It's not just tumor boards. All meetings overlapping prime childcare \u23f0 are a problem\nIn our \ud83c\udfe0, conflicts ov\u2026"]
[8.027270317077637, 9.204934120178223, "RT @AmandaNizamMD: Few things in life can extricate me from Europe 4 days earlier than originally planned, but #UromigosLive is DEFINITELY\u2026"]
[8.093830108642578, 9.337990760803223, "RT @Uromigos: #UromigosLive 2023 will feature a 'Rising Stars' session this year. Promoting the next generation of GU Oncology research is\u2026"]
[9.03787612915039, 7.970041751861572, "@KRejeski @MSKCancerCenter @RShouval @DrMiguelPerales Incredible - Miguel and Roni are both so amazing, and the learning will absolutely be bidirectional!!"]
[9.066716194152832, 8.132121086120605, "RT @drkomanduri: @KRejeski @MSKCancerCenter @RShouval @DrMiguelPerales Enjoy\u2014they are lucky to have you!"]
[9.378518104553223, 9.100780487060547, "RT @KRejeski: Couldn\u2019t be more excited to join @MSKCancerCenter as a visiting investigator in #bmt #celltx !\n\nParticularly excited to hone\u2026"]
[9.05155086517334, 8.366759300231934, "RT @DrMiguelPerales: Welcome to @MSKCancerCenter"]
[8.534428596496582, 9.11851692199707, "RT @DrNikitaMehra: Congratulations, Dr. @cspramesh ! A very proud moment for the Indian oncology community ! @TataMemorial \n@CancerGridIndi\u2026"]
[7.164834499359131, 8.626859664916992, "RT @shhovsepyan: Thrilled to hear about Dr. @cspramesh\u2019s nomination to the #ASCO Board of Directors. His dedication and visionary approach\u2026"]
[10.285273551940918, 11.342175483703613, "RT @GomezDLeonMD: Interested in transplantation and cell therapy in Latinamerica? Are you a hematologist in training, junior faculty or jus\u2026"]
[7.0970540046691895, 8.703310012817383, "RT @drkomanduri: Jason would make an outstanding member of the @ASCO Board of Directors. \n\nBut I\u2019m biased and have known him and have been\u2026"]
[6.7667741775512695, 9.467048645019531, "RT @Lymphoma_Doc: Hey @ASCO members: \n\ud83d\udc40 and \ud83d\uddf3\ufe0f!"]
[10.143275260925293, 10.399908065795898, "RT @sanamloghavi: We have an unexpected #hemepath fellowship opening for 2024-2025 (1 year) at @MDAndersonNews \nCome work with us!!!! We\u2019ve\u2026"]
[8.868083000183105, 12.87553596496582, "RT @kansagraMD: Amazing tweet thread \ud83e\uddf5 by @MyMKaiser on role of MRI in Multiple Myeloma ! \n\nWhat would have taken you hours of reading \ud83d\udcd6 is\u2026"]
[8.452316284179688, 14.359502792358398, "RT @MyMKaiser: Another leap for quality-controlled WB-MRI for #myeloma . Huge opportunity for better imaging data in trials and their analy\u2026"]
[8.230156898498535, 11.67409896850586, "RT @tanyawildes: Great start to the @MyelomaCanada Roundtable with @szusmani speaking on treating newly diagnosed MM in 2023 https://t.co/v\u2026"]
[10.279643058776855, 11.59438705444336, "RT @eemoin: @RahulBanerjeeMD It's really not fun managing severe hyponatremia when you find yourself in the position of asking \"which one o\u2026"]
[6.311592102050781, 10.79294490814209, "RT @pebarba: Torque Teno Virus plasma DNA load: a novel prognostic biomarker in CAR-T therapy. \n\nHappy to have contributed to this study en\u2026"]
[10.497564315795898, 11.737860679626465, "RT @Radhika_Bansl: @RahulBanerjeeMD @ASH_hematology Hahaha! Save the characters\ud83e\udd23\ud83e\udd23"]
[10.0580415725708, 9.4683256149292, "RT @hamzahashmi87: Proud mentor moment: Congrats to @DimaDanai for her oral presentation on RWE of Tec in RRMM at #Ash23 and winning and AS\u2026"]
[10.140613555908203, 9.815536499023438, "RT @thisisJamesD: #ASH23 abstracts are out today and I\u2019m super excited to be a part of 1 oral and 11 posters. A huge congrats to @DimaDanai\u2026"]
[9.495749473571777, 7.3265299797058105, "RT @DrRossanaRosa: @Cortes_Penfield In Spanish they absolutely do:\nLA vancomicina (aka: la vanco)\nLA daptomicina\nEL trimetroprim\nLA doxicic\u2026"]
[8.747246742248535, 13.134500503540039, "RT @i3health: Presented by leading expert Urvi Shah, MD, Assistant Attending in the Myeloma Service at @MSKCancerCenter, this activity will\u2026"]
[7.650737762451172, 11.511104583740234, "@eemoin Couldn\u2019t agree more :( and for the patient who unfortunately requires q4h IV pain meds throughout the night, suddenly it\u2019s only been \u201c3\u201d hours\u2026"]
[8.491738319396973, 10.8801908493042, "RT @eemoin: If you're on the fence about making daylight saving time permanent, consider that many hospitals\u2014perhaps where you or a loved o\u2026"]
[8.292211532592773, 9.437712669372559, "RT @ASCO: We're pleased to be at the Indian Cancer Congress #ICC2023! Visit our booth to learn about our latest resources for the global on\u2026"]
[9.27116870880127, 13.022665977478027, "RT @JoshuaRichterMD: Putting together a section of a talk about the history of myeloma.    Thinking of the title \u201csee Kyle\u201d.  To anyone loo\u2026"]
[8.059053421020508, 12.941591262817383, "RT @kansagraMD: Plenary Session #mmsm \n\nIsaKRD vs. KRD in Transplant eligible #MultipleMyeloma \n\nPrim Endpoint: MRD -ve by NGS 10-5 after c\u2026"]
[10.383907318115234, 12.01060676574707, "RT @Radhika_Bansl: \ud83d\ude03 Upcoming Oral presentation on our outpatient practice @ASH_hematology #TcellRx #BsAb #mmsm #lymsm #ASH2023 \n\n\ud83d\udce3 A big s\u2026"]
[6.989931583404541, 8.949382781982422, "RT @Lymphoma_Doc: Hey @ASCO! \nThe ASCO Election is open, and I am humbled to be a candidate for the Board of Directors. \nClick \u2b07\ufe0f to learn\u2026"]
[10.836339950561523, 11.14554500579834, "RT @DiMengyang: Yes, it\u2019s #ASH23 (to save two characters)!\nLook forward to seeing old friends/colleagues and to meeting new friends/collabo\u2026"]
[10.364340782165527, 11.816995620727539, "RT @Thatquaratined1: @RahulBanerjeeMD @Ghoshomy @ASH_hematology Not to mention if Twitter (X) will even be around"]
[10.877809524536133, 11.08957290649414, "RT @DrPaulyDeSantis: Endorse \u2705 #ASH23"]
[10.20677661895752, 12.194572448730469, "RT @akshatdoctor: @ASH_hematology @RahulBanerjeeMD @mshadman @fredhutch @ASHClinicalNews @szusmani @Myeloma_Society #ASH23 it is ! \nPresent\u2026"]
[8.45501708984375, 9.22118091583252, "RT @PGrivasMDPhD: Our @fredhutch GU dreamteam is hiring 2 med onc faculty (1 prostate focused &amp; 1 bladder focused): spread the word, tremen\u2026"]
[9.962485313415527, 8.058793067932129, "@DrNikitaMehra @TheLancetHaem \u0935\u0940.\u092a\u0940.\u090f\u0928. \u091c\u093f\u0902\u0926\u093e\u092c\u093e\u0926!!"]
[9.753633499145508, 8.36508560180664, "RT @aditishasMD: @GKaurMD @UTSWInternalMed @FiekeHoff @flatironhealth @RahulBanerjeeMD @ManniMD1 Wow congratulations @GKaurMD and team! \ud83c\udf89 N\u2026"]
[10.386710166931152, 7.889219760894775, "RT @bdermanmd: One of those days... https://t.co/RfQymjrgly"]
[8.666953086853027, 11.632808685302734, "Excellent @JCOOP_ASCO commentary by @amarkelkar @DrCCutler et al about AI in oncology!\n\nWhere the Watson super-computer once failed in oncology, AI will likely succeed - but important to understand its limitations and biases upfront as we venture forward with these use cases\u2026 https://t.co/lE9WXF2RNL"]
[8.529379844665527, 11.35627555847168, "RT @amarkelkar: 4/ Bias: Patient-facing AI also carries risk for introducing bias based on the selection of training data combined with lim\u2026"]
[8.583264350891113, 11.123988151550293, "RT @amarkelkar: 3/ Perils\ud83d\ude1f: Patient-facing AI could also lead to harm human dignity and therapeutic relationships by diminishing the respec\u2026"]
[8.557723045349121, 11.22563362121582, "RT @amarkelkar: 1/ #AI in Oncology\ud83e\ude7a: Today in @JCOOP_ASCO, we explore &amp; provide guidance on AI that directly interacts with patients, calli\u2026"]
[7.784204483032227, 11.081610679626465, "I can\u2019t emphasize these enough!!\n\n\ud83d\udcabAwesome work by @FiekeHoff - looking forward to her #ASH23 oral about Velcade dosing!\n\n \ud83d\udcab \u201cCOI\u201d in action: two advisors met after an ad board and decided to prove our point to our industry partners. Hopefully whole #MMsm field will benefit! https://t.co/MOHJ5WY5EB"]
[9.643332481384277, 8.542802810668945, "@GKaurMD @UTSWInternalMed @FiekeHoff @flatironhealth @ManniMD1 Yes indeed - while we disagree on one person\u2019s influence, I appreciate @ManniMD1\u2019s public and private shoutout for this excellent work by all-star @UTSWInternalMed resident @FiekeHoff !"]
[9.706377983093262, 8.400115013122559, "RT @DrNikitaMehra: @GKaurMD @UTSWInternalMed @FiekeHoff @flatironhealth @RahulBanerjeeMD @ManniMD1 Congratulations, @GKaurMD,  @RahulBanerj\u2026"]
[9.84199047088623, 8.204726219177246, "@DrNikitaMehra He loves his Akkad bakkad book so we will return the favor by getting you guys something!!"]
[9.00439739227295, 7.577243328094482, "@DurbVurb @AnthemBCBS Heh - if only I could have billed for the amount of emails behind the scenes as we navigated this\u2026 thank goodness for the PFS team!"]
[9.36712646484375, 7.932046413421631, "@thisisJamesD @AnthemBCBS Thank goodness for talquetamab!!"]
[9.777448654174805, 8.090184211730957, "RT @DrPaulyDeSantis: @RahulBanerjeeMD @BloodJournal @romeerizwan @NikhilMunshiMD This is awesome \ud83e\udd29"]
[9.756012916564941, 9.062743186950684, "RT @FiekeHoff: Great collaboration! Thanks @GKaurMD @RahulBanerjeeMD @flatironhealth and team!! RW data shows that twice-weekly bortezomib\u2026"]
[6.68134069442749, 9.562682151794434, "RT @Lymphoma_Doc: This is so important: Prior Authorization is often abused to delay justified treatment/tests. @ASCO and others have advoc\u2026"]
[10.214993476867676, 7.8148722648620605, "RT @DGlaucomflecken: \ud83d\udea8PRIOR AUTHORIZATION REFORM\ud83d\udea8 https://t.co/9mqK5GHAME"]
[7.534356117248535, 11.946440696716309, "Happy update - after two appeals and my letter offering a free educational phone call about BCMA sequencing in #MMsm, he got approved today for cilta-cel!\n\nThanks @AnthemBCBS for doing the right thing, even if it took 2+ months of my and most importantly my patient's time. https://t.co/NbAYzN9CGo https://t.co/9wIKUsfooF"]
[10.340987205505371, 8.246788024902344, "RT @joshuaafein: @GiraltSergio\u2019s famous slide and its message never get old. #MPN2023 https://t.co/RbBgDDRULh"]
[9.349804878234863, 7.664088249206543, "@Lachelle_Dawn A talk at @fredhutch or somewhere else? If not here, we can figure something out for sure :) And would love to meet in real life!!"]
[7.07245397567749, 12.441329956054688, "Not every day I see \"endoderm\" or \"mesoderm\" in #MMsm papers... this paper is a tour de force!\n\nNow in @BloodJournal by Bae @romeerizwan @NikhilMunshiMD et al: turn\ud83e\udd71exhauted polyclonal BCMA-targeted T cells into\ud83d\udcaa MM-killing ones via iPSC rejuvenation!\n\nhttps://t.co/4m13WTu2BU https://t.co/MgP0w4Swt2"]
[7.037367820739746, 8.83456802368164, "RT @cspramesh: Great opportunity to become a member of @ASCO \nRemember, membership to ASCO is free for LMICs."]
[9.413119316101074, 9.267763137817383, "RT @ErikaHamilton9: Fantastic news for those with small children who want to present their research and/or learn. \n\nCongrats #SABCS23."]
[7.106799602508545, 9.239089012145996, "RT @mshadman: @Lymphoma_Doc will be a great advocate! Would be great to see him on the @ASCO board of directors."]
[8.347119331359863, 12.495842933654785, "RT @GKaurMD: The number of #MGUS consults would drop and that then will reduce the # of patients coming to see an oncologist for a conditio\u2026"]
[9.473623275756836, 8.729039192199707, "RT @CraigEmmittCole: @jmikhaelmd @Amyloid_Planet @karmanoscancer @IMFmyeloma @domenica76 The IMF\u2019s M-Power program came to Tabernacle Missi\u2026"]
[8.880961418151855, 13.134117126464844, "RT @grpetersen1: United Health Care Qualifications- A high school grad making decisions on my MYELOMA Specialist treatment plan! NUTS\nREQUI\u2026"]
[10.048796653747559, 8.343811988830566, "RT @CoachBon: @RahulBanerjeeMD Hoping the infection rates aren't higher..."]
[8.744386672973633, 13.2373046875, "RT @End_myeloma: Refreshing to see an academic collaboration trial providing \"ready to use\" , context-relevant results getting stage time a\u2026"]
[5.659116268157959, 11.494749069213867, "RT @gjmccaughan: Looking forward to hearing how we might be able to minimise toxicities of bispecifics at #ASH23 including \n\nLess frequent\u2026"]
[6.832554817199707, 11.38874626159668, "RT @bdermanmd: @RahulBanerjeeMD @chngwj I love CyPomDex and think it will be used more in coming years based on early usage of so many othe\u2026"]
[10.161291122436523, 8.148252487182617, "RT @MMKingT: Key word accessible- congrats @chngwj"]
[6.907680511474609, 11.547137260437012, "I\u2019ve definitely lost some of my enthusiasm for frontline Cy in #MMsm based on \ud83c\uddeb\ud83c\uddf7 Bridoux CyBorD vs Vd trial, but this is a good reminder of the drug\u2019s utility in the relapsed setting.\n\n#ASH23 Pom/Cy/dex vs pom/dex (the sledgehammer of control arms). \n\nGreat work @chngwj et al! https://t.co/knJxGuJrHU"]
[9.037110328674316, 9.534591674804688, "RT @Rfonsi1: A wonderful day today, learning from my colleagues, Dr. @DrKrinaPatel, @Ccostello7 &amp; Udit Yadav from a great dialogue with pat\u2026"]
[6.1401777267456055, 11.037920951843262, "@YLeyfman I completely agree!! All fascinating questions - or bicistronic CAR-T cells that have different CARs on the same cell\u2026 time will tell!"]
[6.52335786819458, 11.000947952270508, "RT @YLeyfman: Researcher from Columbia University develop a probiotic platform to guide CAR T cells to more effectively target and eradicat\u2026"]
[6.007779121398926, 11.205954551696777, "@YLeyfman Completely agree! The other nuance with bsAbs will be whether 2 &gt; 1 if they\u2019re on the same molecule - one theoretical downside of 8 different bsAbs at once is that whichever one binds first will be the one that sticks around\u2026"]
[5.916834354400635, 10.845562934875488, "RT @YLeyfman: @RahulBanerjeeMD This is a truly interesting approach. However we had armored CARs but I have not heard much about them latel\u2026"]
[7.764261722564697, 11.815871238708496, "RT @JCOOP_ASCO: \ud83d\udcbbBlack pts were less likely to have #telehealth visits than White pts (29 v 71%). Black survey participants more often repo\u2026"]
[8.844643592834473, 8.866698265075684, "RT @Florez_Lab: Happy birthday to superstar @AnaVManana! \ud83c\udf70\ud83c\udf82\n\nA passionate Thoracic oncologist @UCSFCancer, #DEI advocate, &amp; mentor per-exce\u2026"]
[8.23704719543457, 9.302895545959473, "RT @koshkin85: Great to see several intriguing  #BladderCancer concepts presented by   @uromigos rising \u2b50\ufe0fs! After much discussion and refi\u2026"]
[5.935941219329834, 11.162688255310059, "This is fascinating!! We talk about \u201cCAR-pools\u201d of two mono-targeted CARs infused together, or of tec/tal combos in #MMsm from RedirecTT-1.\n\nBut maybe we can target two on the same bsAb - looking forward to this at #ASH23! https://t.co/PpnmbyOqlG"]
[10.939634323120117, 12.111749649047852, "RT @iHematologo: One small inclusion detail I would feedback to @ASH_hematology is that the Abstract Platform deals poorly with internation\u2026"]
[7.138017177581787, 13.343489646911621, "RT @Taxkourel: @bdermanmd a gk is there on ife right? Dara should not cause a \u2b06\ufe0fenough m spike to confidently report. M spikes &lt; 0.3 overes\u2026"]
[7.153759479522705, 13.426713943481445, "RT @bdermanmd: A patient is on daratumumab for a while and they no longer have a detectable IgG Kappa M-spike that was previously attribute\u2026"]
[10.150352478027344, 9.288996696472168, "RT @SusanBal9: @bdermanmd We have been monitoring with mass spec and interestingly in cases where no longer seen by IFE, still seen on mass\u2026"]
[6.460892677307129, 11.896173477172852, "RT @MeeraMohanMD: Check out our oral abstract on efficacy and safety of standard-of-care teclistamab\n#mmsm #ASH23 @MCWCancerCenter \n@rajshe\u2026"]
[10.165014266967773, 9.21401309967041, "RT @OncData: Looking for updates from #IMS23? Check out this podcast in which @ShoMidha talks with @RahulBanerjeeMD about her presentation\u2026"]
[9.638652801513672, 8.873204231262207, "RT @AJPortuguese: @tanyawildes @RahulBanerjeeMD The real \"No Duh!\" moment came when I learned that our CGAT lab can automatically identify\u2026"]
[9.504386901855469, 8.950542449951172, "@DrNikitaMehra @CI_WIA Wonderful to see and kudos to you for this AMAZING work!!!"]
[8.150354385375977, 9.43311882019043, "RT @DrNikitaMehra: I would like to thank the Indian Society of Medical &amp; Paediatric Oncology for recognising our work identifying a low cos\u2026"]
[7.846548080444336, 10.59001636505127, "@tanyawildes @fredhutch @AJPortuguese @BloodAdvances Heh - was this for this post or my latest diatribe against an insurance company playing games with patient well-being?\n\nAlways an appropriate reaction either way!"]
[10.023027420043945, 8.176506996154785, "RT @tanyawildes: @RahulBanerjeeMD @fredhutch @AJPortuguese @BloodAdvances https://t.co/niDfFPXxv6"]
[7.818478584289551, 10.630668640136719, "@jmaakaron @seattletimes Agreed \u2013 this is so unnecessary! I cannot even begin to fathom why the health insurance company would do this to its beneficiary\u2026"]
[7.402535915374756, 11.366240501403809, "RT @jmaakaron: @RahulBanerjeeMD @seattletimes Isn't it well within the scope of practice of pharmacists to exchange generics for brands in\u2026"]
[7.741369247436523, 10.994022369384766, "RT @i3health: In this activity presented by @RahulBanerjeeMD, Assistant Professor at @UW and @fredhutch, gain expert insights into the use\u2026"]
[6.381612300872803, 11.40509033203125, "Fascinating #MMsm work by my new @fredhutch colleague @AJPortuguese, now out in @BloodAdvances!\n\nI learned rather quickly that BCMA is on chr 16p vis-\u00e0-vis CAR-T therapy, but somehow I'd never pondered this for CD38...\n\n\ud83d\udc40chr4 deletions as a driver of dara/isa resistance! https://t.co/mdRWhcRJwF https://t.co/vCu8vU1tPa"]
[8.4653959274292, 10.410585403442383, "RT @CterminiPhD: Phew... 1st research article as the corresponding author out in @Haematologica! \u2764\ufe0f\ud83e\ude78\n\n\"Examining the impact of age on the p\u2026"]
[7.5048933029174805, 11.52869701385498, "@seattletimes Even more interestingly, generic lenalidomide is exactly what I'd prescribed! https://t.co/G9NPsOUNEw https://t.co/N5cGDVoPaS"]
[7.548774242401123, 11.565459251403809, "Great work by @CoordinatedCare (WA state Medicaid) - denying Revlimid to my newly diagnosed patient with #MMsm so you can try \u201clenalidomide\u201d instead.\n\nBetter to deny request and delay the patient\u2019s care than to assume that 100% of physicians wouldn\u2019t mind starting generic len. https://t.co/frU3fddGYg"]
[10.395848274230957, 9.627269744873047, "To paraphrase from the Marvel Cinematic Universe - now that the \u201csacred timeline\u201d of t(11;14) management in #MMsm has fractured with CANOVA,\n\nMany promising variants have emerged.\n\nGreat work @HangQuach1 @SusanBal9 @bhemato et al at #ASH23! https://t.co/Zlyb1pDVSU"]
[9.05606746673584, 13.373196601867676, "RT @Abdallah81MD: GLAMM1 Study - Global Access to Myeloma Medications: Potential Barriers to CART and TCE Globally by #USMIRC group @Rawana\u2026"]
[8.116022109985352, 11.988893508911133, "RT @HiraSMian: # 2: Stellar work exploring real-world outcomes in patients with MM for each contemporary regimen in Canada with @VisramAlis\u2026"]
[10.028336524963379, 9.816104888916016, "RT @HiraSMian: Excited for our group to have two oral presentations this year # 1: Post BCMA Outcomes with @Rfonsi1 #ash2023 https://t.co/1\u2026"]
[7.929320812225342, 12.624677658081055, "RT @nihardesai7: Contrary to popular opinion, the frailer the patient with myeloma, the more they seem to benefit from VRd vs Rd !\n\nEffecti\u2026"]
[7.095242977142334, 9.578585624694824, "RT @YLeyfman: Thank you to the Lymphoma, Leukemia &amp; Myeloma Congress for this prestigious recognition. I am deeply grateful to Dr. Park for\u2026"]
[6.412314414978027, 11.212044715881348, "RT @drjgauthier: CD19 targeting with loncastuximab or tafasitamab prior to CD19 CAR T-cell therapy.\nMight share my own thoughts later \ud83d\ude09\n(Fe\u2026"]
[10.271763801574707, 8.461929321289062, "RT @mtmdphd: #mmsm #geriheme #gerionc"]
[7.89486026763916, 12.447458267211914, "@IMiDs_elderly @KonLontos @BloodAdvances @NikhilMunshiMD All great points - I would still argue that they speak to the idea of \u201cdynamic frailty\u201d as @HiraSMian @tanyawildes et al have spoken to. I\u2019ve seen it in real life for sure!\n\nWhether Rd vs Vd would perform is a great question - hard to say, and I\u2019m glad they used both in triplet!"]
[7.757186412811279, 12.439388275146484, "EXCELLENT @BloodAdvances work by Dumontier @NikhilMunshiMD et al using \ud83c\uddfa\ud83c\uddf8 VA data.\n\nVRd &gt; Rd in #MMsm \u00e0 la S0777 as expected, BUT:\n\nThe frailer the patient, the more they stand to benefit from triplet vs doublet induction \ud83e\udd2f OS curves below!\n\nhttps://t.co/JEUpWiu9rr https://t.co/RrAvgyJeJ0"]
[9.183465003967285, 12.581708908081055, "RT @VincentRK: Kudos to the International Myeloma Society (IMS) for sending a survey to its members on ABIM MOC. Please participate! \n\n@Mye\u2026"]
[6.629231929779053, 11.866867065429688, "RT @bhemato: Phase I results of Sonrotoclax in t (11;14) in RRMM; safe and promising efficacy with 70% ORR in TCE pts. Look forward to get\u2026"]
[8.187841415405273, 12.933944702148438, "RT @DrChoueiri: JUST IN (and finally...): Pembrolizumab hits OVERALL SURVIVAL in KYN-564 adjuvant study in Kidney Cancer!!!\n\nThe time has f\u2026"]
[8.736649513244629, 10.189359664916992, "A visual representation of medical progress and innovation. Wow!\n\nCongrats to the team behind this trial. https://t.co/SSOY4LnXkL"]
[9.967077255249023, 11.554532051086426, "RT @Dr_AmerZeidan: I rarely endorse in @ASCO or @ASH_hematology elections publicly with many outstanding candidates, but let me just say th\u2026"]
[10.858489036560059, 11.109537124633789, "RT @RahulBanerjeeMD: Trying to move on this preemptively - only with all of your help can we finally have a unified hashtag for #ASH23!\n\nSe\u2026"]
[9.531764030456543, 7.4592390060424805, "@chano_py Muchas felicidades!"]
[9.537765502929688, 7.343572616577148, "RT @jdgoldestein: Es @JMilei hoy y siempre es el estado Narcochavista o la Argentina de bien que nos merecemos\nNos jugamos todo https://t.c\u2026"]
[9.201598167419434, 7.530089378356934, "@JoshuaRichterMD @DrKrinaPatel @Ccostello7 @HealthTree @AhlstromJenny @MyelomaTeacher @ASU @michaelcrow Next time. Fall/winter in Phoenix is sweet!"]
[8.482880592346191, 8.383381843566895, "RT @HealthtreeMM: Thank you \u2066@Rfonsi1\u2069 for hosting this amazing day at the #HealthTreeMM Phoenix Roundtable. Loved hearing about MM markers\u2026"]
[9.20841121673584, 8.952860832214355, "RT @MyelomaTeacher: A grateful shout out to Drs. @Rfonsi1, @Ccostello7, @DrKrinaPatel, Yadav (not pictured) and Adamski for a fantastic @He\u2026"]
[8.466438293457031, 10.485795974731445, "A wonderful day today, learning from my colleagues, Dr. @DrKrinaPatel, @Ccostello7 &amp; Udit Yadav from a great dialogue with patients. Thanks to @HealthTree, @AhlstromJenny &amp; @MyelomaTeacher for being such leaders in this area. Thank you @ASU and @michaelcrow for your hospitality\u2026 https://t.co/DpNrT9UMfs https://t.co/asjJsjqLDW"]
[9.356054306030273, 7.7597832679748535, "@Theholisticpsyc Always spot on!"]
[8.833768844604492, 9.367035865783691, "RT @Theholisticpsyc: Most people don't want the truth.\n\nThey want their beliefs reinforced. \n\nThe truth is appreciated by those who have co\u2026"]
[8.16154670715332, 8.991281509399414, "RT @JoshEakle: Did you know?\n\nMillennials are exactly on track with their wealth accumulation relative to previous generations.\n\nNo, they a\u2026"]
[8.855252265930176, 9.678654670715332, "RT @TheBabylonBee: Tragic: Mom Forgot To Have Her Baby Do Tummy Time For One Day And Now His Head Is Shaped Like A Box https://t.co/psVRi8R\u2026"]
[6.787258148193359, 10.666024208068848, "My favorite videos. T cells killing cancer cells https://t.co/XWPvJyuSPJ"]
[6.732635021209717, 11.441191673278809, "RT @tobyeyre82: Chavez et al\n3Y fup of ZUMA12\n\nAxicel for 40 pts with double/triple hit or IPI\u22653 who have a iPET+ve post 2 anti-CD20 monocl\u2026"]
[8.884400367736816, 9.307381629943848, "RT @HealthtreeMM: Our esteemed panel with \u2066@Rfonsi1\u2069 \u2066@Ccostello7\u2069 \u2066@DrKrinaPatel\u2069 and Dr. Yadav was a full day of incredible education at\u2026"]
[7.371182441711426, 8.787043571472168, "While we will miss Alan, he continues to have a stellar trajectory and is also a great human being. https://t.co/VZOGiulVxu"]
[10.794300079345703, 10.43359661102295, "@mtmdphd @BloodAdvances @RahulBanerjeeMD Similar data from MAIA https://t.co/OJ3QhHUGNz"]
[10.729717254638672, 10.628957748413086, "@nihardesai7 @DrNikitaMehra @NicoGagelmann @BloodAdvances @Prasshmehta @Abdallah81MD @MorphologyAmigo @lingarajnayak @IMFmyeloma @TikareNakul Same observations in MAIA https://t.co/4tsrLkqAPd"]
[9.535440444946289, 7.4204888343811035, "@BrincoBrinco Nothing like Latin rhythm"]
[6.916017055511475, 8.437183380126953, "I\u2019ve put my votes in and one of them of course went to Toni!  Good sense of direction for ASCO. https://t.co/SW8m8n3NZ9"]
[8.000882148742676, 12.132570266723633, "RT @HiraSMian: Our thoughts on MRD in older adults with MM.  MRD and frailty both need similar approaches....need to be routinely evaluated\u2026"]
[10.02121353149414, 11.933134078979492, "@HiraSMian @smith__giri @tanyawildes @BloodCancerJnl @ECRI_RESEARCH I have re-read and the message is good!4"]
[10.789631843566895, 10.802755355834961, "@mbeksac56 @mtmdphd @BloodAdvances @RahulBanerjeeMD I think ASH is OS and MAIA PFS?"]
[7.104343414306641, 11.223409652709961, "Should I Be Taking Supplements? Only a handful out of 95,000 on the market actually help in a few situations https://t.co/0JfMaw3ge4"]
[8.434016227722168, 9.850847244262695, "Why doctors in America earn so much https://t.co/GOKjiiVhDj from @TheEconomist https://t.co/GOKjiiVhDj"]
[6.980241775512695, 9.024968147277832, "RT @sairah__ahmed: \ud83d\uddf3 Vote for @ASCO positions! I'm privileged to work with Jason @Lymphoma_Doc and he is a tireless advocate for both patie\u2026"]
[8.43308162689209, 14.38658332824707, "RT @MyMKaiser: Another leap for quality-controlled WB-MRI for #myeloma . Huge opportunity for better imaging data in trials and their analy\u2026"]
[10.861369132995605, 11.979264259338379, "ASH Annual Meeting Abstracts out now #ASH23 @ASH_hematology @ASHClinicalNews \n\nhttps://t.co/LDRiV3ia9Y"]
[8.47441577911377, 10.391471862792969, "RT @DrAmyComander: Happening now at #LM2023! Dr. Amber Orman, Sami Mansfield, &amp; I are leading our workshop: \u201cThe Role of Lifestyle Medicine\u2026"]
[8.909788131713867, 8.313251495361328, "@KRejeski @MSKCancerCenter @RShouval @DrMiguelPerales Congratulations! Welcome to MSK!"]
[8.020075798034668, 10.771750450134277, "RT @DrJacobMirsky: For any #primarycare providers looking for some joy in practice, consider starting a #FoodIsMedicine initiative in your\u2026"]
[10.074243545532227, 12.29746150970459, "Environmental air pollution may affect myeloma survival! Zip code matters \n\nCongratulations @michaelwysotaMD and @aditishasMD on this novel and important work\n\n#mmsm #bmtsm #ASH23 @ASH_hematology \n\nhttps://t.co/uViy19SDH2 https://t.co/MMbDFrcOuv"]
[9.46471118927002, 8.765222549438477, "@MGHLifestyleMed @DrAmyComander @bewellwithsami @HundalJasmin @ACLifeMed @MGHCancerCenter @MassGenBrigham Yes of course! Glad to see this workshop on the agenda!"]
[9.827341079711914, 9.57573127746582, "RT @redcell_doc: So proud to be part of a division that supports #classicalheme throughout the entire trainee spectrum. Coagulations, indee\u2026"]
[8.75687313079834, 7.799936771392822, "@drteplinsky @nycmarathon Good luck!! \ud83c\udf40 \ud83d\udc95"]
[8.491677284240723, 9.566344261169434, "RT @maryam_lustberg: Really incredible @ALLIANCE_org Fall meeting to advance current cancer care. https://t.co/eAQZw0hBnZ"]
[9.436379432678223, 7.712244033813477, "@sardesai_sagar @JasmineSukumar @maryam_lustberg @ALLIANCE_org Awesome see you at the session tomorrow"]
[8.8194580078125, 8.543754577636719, "@MalinHultcrantz @FredsTeam @MSKCancerCenter Amazing congratulations Malin!"]
[9.165190696716309, 9.205681800842285, "@sardesai_sagar @MSKCancerCenter @ALLIANCE_org Thanks Sagar, great to see you at the meeting and hear about your research too!"]
[8.511653900146484, 9.609145164489746, "Congratulations @sardesai_sagar @JasmineSukumar @maryam_lustberg \nEnjoyed hearing about the initial stages of your trial at #TREC and seeing the final results on episodic future thinking and delayed discontinuing as a weight loss intervention in breast cancer @ALLIANCE_org #bcsm https://t.co/dz6o3oU1r6"]
[8.108680725097656, 9.506231307983398, "RT @HundalJasmin: Only 16% of #cancersurvivors meet #exercise recommendations, despite the known benefits of movement, muscle building, and\u2026"]
[8.985055923461914, 8.258744239807129, "@DrNikitaMehra @CI_WIA Amazing! Congratulations Nikita!"]
[9.141529083251953, 9.20873737335205, "Allyship is important but collaboration and partnerships are key action items to success - important words from @EdithMitchellMD \n\n@IMFmyeloma @jmikhaelmd @NorthTxMSG #imfmpower #mmsm https://t.co/Tjcw3Vgo5k"]
[9.542810440063477, 9.992493629455566, "Look forward to talks with amazing speaker line up at the @IMFmyeloma African American Initiative Council meeting @jmikhaelmd @NorthTxMSG @Amyloid_Planet @CraigEmmittCole @szusmani Much work needed in this area to educate engage and enhance: M-power #mmsm https://t.co/ki9NwMrg3k"]
[8.471684455871582, 10.596576690673828, "RT @NYCFoodPolicy: Don't miss our Food as Medicine: Treating Disease Virtual Event! It will occur on Wednesday, November 15, from 9:30AM to\u2026"]
[8.972908020019531, 8.614738464355469, "Congratulations!! @Neil_Iyengar so well deserved @MSK_DeptOfMed https://t.co/dBAI3NbWjl"]
[9.561274528503418, 7.6590423583984375, "@GoHealio"]
[8.51324462890625, 10.219828605651855, "@ShikhaJainMD interviews @DrAmyComander on the importance of lifestyle medicine in cancer care! Dr Comander is inspirational and I highly recommend this episode! Also thanks for the shout out of our work in myeloma #lifestyle #bcsm #mmsm #cancer #CancerResearch https://t.co/UP6NLwnAGH"]
[7.83141565322876, 14.132285118103027, "RT @FrancescoMaura4: New study from the lab out today on @NatureCancer \ud83d\udd25\ud83d\udd25. We integrated #wgs and #scRNA to investigate why multiple myelom\u2026"]
[9.093218803405762, 13.016641616821289, "RT @theMMRF: We\u2019re excited to announce the launch of our Myeloma Accelerator Challenge Program\u2014a new multi-institutional, translational res\u2026"]
[9.27067756652832, 10.514086723327637, "@JKaufmanMD All good! Had multiple pt conversations about amyloid + biopsies without typing ordered - frustrating though!"]
[7.162734031677246, 13.315669059753418, "A patient is on daratumumab for a while and they no longer have a detectable IgG Kappa M-spike that was previously attributed to dara. I've noted a number of times, and wonder if drug is being 'cleared' too quickly. Does anyone think 're-induction' works if waning response?"]
[10.658306121826172, 7.977412223815918, "One of those days... https://t.co/RfQymjrgly"]
[7.696834087371826, 11.641234397888184, "@CoachBon @ManniMD1 @rajshekharucms @Eddie_Cliff But those abnormalities do suggest that a more intensive approach would be needed once treatment commences. So it\u2019s a little like getting on a train and there won\u2019t be a station to get off for a long while."]
[7.604615211486816, 13.090813636779785, "@CoachBon @ManniMD1 @rajshekharucms @Eddie_Cliff My 2 cents on top of Manni\u2019s very good explanation - some cytogenetic abnormalities predict higher risk of progression: gain 1q for example. This is part of the IMWG risk score for smoldering. But it doesn\u2019t apply here because that excluded patients with SLiM criteria."]
[6.99739408493042, 11.592174530029297, "@RahulBanerjeeMD @chngwj I love CyPomDex and think it will be used more in coming years based on early usage of so many other anti myeloma agents"]
[9.868985176086426, 9.514973640441895, "@your_hemoncdoc @UChicagoHemOnc And you did a fantastic job!! Kudos! Now if only we can convince you to come to the Heme side!!!"]
[9.660930633544922, 7.660063743591309, "@Thatquaratined1 yes!"]
[7.255256175994873, 13.583884239196777, "@Thatquaratined1 Dara (or isatuximab or elotuzumab) will usually appear as an IgG Kappa spike on IFE. When a patient has anything other than IgG Kappa myeloma, the monoclonal antibody drug is usually easily discernable from the myeloma paraprotein. But when both are IgG Kappa, it is harder."]
[7.767866611480713, 12.441285133361816, "@mbeksac56 @Rfonsi1 @mtmdphd @BloodAdvances @RahulBanerjeeMD Message seems to be that the direction of benefit is the same for all.\nSome takeaways:\n1) Frail patient benefit from triplet the greatest b/c relapsing pts don't do well (PFS1 is paramount).\n2) Triplet therapy may improve PS in frail pts, leading to access to other therapies"]
[9.322821617126465, 12.262901306152344, "@tanyawildes @HiraSMian Two incredible myeloma physicians, human beings and dear friends!!"]
[9.393231391906738, 13.04687786102295, "M-Power Detroit - changing the course of health disparities in myeloma! Amazing faculty @Amyloid_Planet @CraigEmmittCole @karmanoscancer @IMFmyeloma @domenica76 https://t.co/vbXbkfNm5f"]
[9.399300575256348, 12.942503929138184, "M-power Detroit has started! Blessed to have Pastor Johnson welcome us to the Tabernacle Missionary Baptist Church. We can be empowered to change the course of myeloma and reduce health inequity #whereisdrjoe #mpower @IMFmyeloma @NorthTxMSG https://t.co/LEIgORVYbS"]
[9.67699909210205, 9.842483520507812, "RT @UrviShahMD: Look forward to talks with amazing speaker line up at the @IMFmyeloma African American Initiative Council meeting @jmikhael\u2026"]
[8.97627067565918, 13.063047409057617, "RT @NorthTxMSG: In 2023, our M-Power initiative achieved remarkable milestones, fostering diversity and equity in myeloma care. Together, w\u2026"]
[9.0626802444458, 12.767420768737793, "RT @IMFmyeloma: In this episode \"Myeloma Made Simple,\u201d IMF Chief Medical Officer Dr. Joseph Mikhael @jmikhaelmd explores the inequities in\u2026"]
[9.217970848083496, 7.698553085327148, "@MeganWhitney111 @UrviShahMD @BWatsonMD @NorthTxMSG @IMFmyeloma Thanks so much for introducing us to @BWatsonMD Megan! She is amazing."]
[7.483444690704346, 10.316679954528809, "RT @PallawiTorkaMD: #lymsm #drugshortage\n\nWith DACARBAZINE SHORTAGE knocking on our doors again, sharing this article I penned with @drrx4L\u2026"]
[6.723511695861816, 9.724675178527832, "RT @NehaMehtaShahMD: Exciting data @Lymphoma_Doc! We are currently studying acalabrutinib+durvalumab in CNS lymphoma at @WashUOnc and Ohio\u2026"]
[6.337855815887451, 11.069003105163574, "PFS curves for yes vs no active disease at CAR infusion. #ASH23 #lymsm #celltherapy https://t.co/vho0dylKJc"]
[6.310979843139648, 10.404701232910156, "Obinu vs rituximab in 1L MCL (from LYMA trials) @clementinesar #ASH23:\n- Propensity score matching with better marrow (82 vs 63%) &amp; blood (96 vs 73%) MRD negativity with O \n- 5-yr PFS &amp; OS also better with O\nNot an RCT but certainly provocative. #lymsm\nhttps://t.co/ZokOcY4KmS https://t.co/LwDcYPYcLc"]
[6.465517997741699, 10.065752983093262, "Nivo + ibrutinib for R/R CNS lymphoma @Lymphoma_Doc #ASH23:\n- 18 pts, 55% refractory, 89% PCNSL, 50% non-GCB\n- best ORR 78% (CR 50%)\n- mPFS 6 mos (although 18-mo PFS 47%), mOS 25 mos\nCurious to learn more about predictors of longer-term responses. #lymsm \nhttps://t.co/wdra2tjqdj https://t.co/6ZnD0vVjwV"]
[6.362345218658447, 10.666952133178711, "Odronextamab in R/R LBCL after CAR-T @JenCrombieMD #ASH23:\n- 46 pts, 72% refractory to CAR\n- ORR 48% (CR 30%), mDOR/DOCR NR\n- 13% d/c'd due to treatment-related AEs\n- all CRS Gr1-2 (46%), no ICANS w/ 0.7/4/20\nLooking forward to T-cell correlatives. #lymsm\nhttps://t.co/do414bxG8R https://t.co/OlDKY4JQd9"]
[6.439107418060303, 10.447940826416016, "RCHOP + glofi added if high-risk ctDNA in 1L LBCL @falchi_lorenzo #ASH23:\n- Of 121 pts, 24 high risk (suboptimal\u2b07\ufe0fin ctDNA after C1 RCHOP) and glofi added for C3\n- EOT ORR 93% (CR 80%)\n- 46% Gr3+ neutropenia, all CRS Gr1-2 (21%)\nGreat study design! #lymsm\nhttps://t.co/wFOl4ejKiK https://t.co/UaUhhEMV57"]
[6.2858734130859375, 10.93867301940918, "Multicenter study of CAR-T in SCNSL #ASH23:\n- 90 pts, 42% axi-cel, 41% tisa-cel\n- 75% with active CNS dx at CAR\n- 61% ICANS (29% Gr3-4), no Gr5 CRS/ICANS\n- 2-yr PFS: 12% if active CNS dx, 28% if not\n- 2-yr cumulative relapse 77%\nSobering results. #lymsm\nhttps://t.co/0IJ8eAiEtU https://t.co/WBu92Sp5EF"]
[7.363073348999023, 11.836214065551758, "Ventricular arrhythmias &amp; sudden death from acala from 5 pooled trials #ASH23:\n- 1299 pts (&gt;4500 pt-years)\n- 5 fatal events with acala (0.4%), 3 in comparator arms (0.5%)\n- no difference in relative risk between cohorts\nAdds nicely to ALPINE data. #lymsm\nhttps://t.co/wGn1NO323O https://t.co/lIaQba0rj1"]
[6.056620121002197, 10.28426456451416, "1L mosun+pola in unfit/frail older DLBCL @lymphomatic #ASH23:\n-  108 pts, median age 81, time-limited mosun\n- median F/U 7.5 mos (LTFU to be presented)\n- at EOT, ORR 55% (CR 45%)\n- 13 d/c'd due to AEs (lots of severe COVID)\nLooking forward to oral. #lymsm\nhttps://t.co/0fLPAxRh0k https://t.co/28AIBtz9yq"]
[9.042642593383789, 9.79355525970459, "New editorial in @AmerGeriatrics: \"Early promotion for The Golden Bachelor is already serving up a platitude of stereotypes.\" #TheBachelor #ageism cc @Jacawalk @HDayLum\nhttps://t.co/YPdv8szaka https://t.co/KO1VuBFcYU"]
[6.411754608154297, 10.57558822631836, "RCT Nivo +/- RGemOx in 2L ASCT-ineligible LBCL #ASH23:\n- 180 pts, 52% age &gt;75, 37% refractory\n- no difference in 1-yr PFS (28 v 20%) or OS (48 v 58%)\n- more Gr3-5 AEs in nivo arm\n- recruitment stopped d/t futility\nOngoing saga of PD1/PDL1 in LBCL. #lymsm\nhttps://t.co/iH5fc1pR7z https://t.co/RVrg8iiUEo"]
[6.219522953033447, 10.307036399841309, "18-mo f/u of BRUIN (pirto in Richter) @wwierda #ASH23:\n- 82 pts, median 4 LOT\n- ORR 50% (CR 13%), mDOR 7 mos, mOS 12.5 mos\n- 8 pts went to allo (bridging option?)\n- no TEAEs leading to d/c\nDefinite activity for a very tough disease. #lymsm\nhttps://t.co/WQ2wVbsDcO https://t.co/YJfyktawNz"]
[5.99229097366333, 10.836441040039062, "@samyamshon Agreed. What's your preferred CAR product for RT?"]
[6.340498924255371, 10.230050086975098, "Poll for #lymsm &amp; #leusm: 70 y/o with history of del17p CLL s/p 1-year ven/obinu. Developed ABC-DLBCL two months after VO completion. Got pola-R-CHP x 3 then admitted to hospital with frank symptomatic progression d/t pleural effusions. What would be your next step? #celltherapy"]
[8.144149780273438, 11.228919982910156, "RT @CharlesMilrod: Picture this:\n\nA patient presents with abdominal pain, and you find this \ud83d\udc47 on your evaluation. \n\nWhat\u2019s going on? \ud83e\udd14 \n\nA\u2026"]
[9.132302284240723, 7.318538188934326, "@AdamKittai @samyamshon @dgermain21 Yeah, I'm planning for epco --&gt; CAR-T."]
[10.185864448547363, 10.453376770019531, "RT @sanamloghavi: We have an unexpected #hemepath fellowship opening for 2024-2025 (1 year) at @MDAndersonNews \nCome work with us!!!! We\u2019ve\u2026"]
[6.892033576965332, 8.470841407775879, "RT @ASCO: Voting for the ASCO Election is now open. All eligible members are encouraged to cast their ballots.\n\n\ud83d\uddf3\ufe0f Vote now: https://t.co/a\u2026"]
[8.329307556152344, 8.294702529907227, "RT @DavidSteensma: An article I wrote on the history of stamp/philatelic vignettes @JAMA_current &amp; @MayoProceedings and Bob Kyle's contribu\u2026"]
[6.947936058044434, 8.402396202087402, "RT @tmprowell: What a talented roster of candidates for the ASCO Election! All ASCO members should vote, but we truly cannot lose with this\u2026"]
[6.941827297210693, 8.449981689453125, "RT @n8pennell: Please vote and help choose the next group of @ASCO leaders!"]
[7.068795204162598, 10.40076732635498, "#ImmunoOnc #kcsm https://t.co/VcXs82X69P"]
[8.4989595413208, 9.184091567993164, "RT @PGrivasMDPhD: Amazing leadership @ASCOPres @jrgralow highlighting the impact of global oncology efforts! @OncoAlert @fredhutch @FredHut\u2026"]
[6.838788986206055, 9.595846176147461, "MT @Lymphoma_Doc [2019 Nov 14] Remember to donate to CCF -&gt; Great to see my friend @mtmdphd at the @ASCO board of directors meeting. Thank you to @ConquerCancerFd for funding our innovative research with a YIA and CDA, an incredible boost for early career oncologists. #lymsm https://t.co/U6fQ8zBY0D"]
[7.617433071136475, 9.137954711914062, "EVERY CANCER. EVERY PATIENT. EVERYWHERE.\n@ConquerCancerFd of the American Society of Clinical Oncology (@ASCO) raises funds to support the world's leading researchers who are improving treatments &amp; discovering cures for patients around the world. https://t.co/du6r6gdsgV"]
[6.5979838371276855, 11.883124351501465, "RT @chanyooncheah: #ASH23 Iacoboni et al: retrospective data suggesting bendamustine exposure may not negatively impact treatment outcomes\u2026"]
[5.782940864562988, 9.667264938354492, "Ilyad: A Phase III DB-RCT Evaluating Vitamin D (Cholecalciferol) in Pts w/ Low Tumor-Burden Indolent Non-Hodgkin Lymphoma Treated with Rituximab Therapy [Dec 10, 2023] @DrJFriedberg et al. #ASH23 Abst 606 https://t.co/LMlsS0kyJM #lymsm HT @chanyooncheah https://t.co/3nXik7RnaP"]
[6.184131622314453, 9.463329315185547, "Bone Loss in Lymphoma Pts Receiving Frontline Therapy: Urine NTx &amp; Bone Specific Alkaline Phosphatase Provide Early Evidence of Zoledronic Acid Response [Nov 20, 2009] @Lymphoma_Doc @mtmdphd @vincedcataldo et al. #ASH09 Abs 3922 https://t.co/hrBt2uSIey #lymsm #BoneHealth #SuppOnc"]
[6.138004779815674, 9.512123107910156, "Bone Loss in Patients with Previously Untreated Lymphoma: The Effect of Periodontal Disease on the Use of Zoledronic Acid [Nov 16, 2008] @vincedcataldo @mtmdphd et al. #ASH08 @BloodJournal (2008) 112 (11): 5297 https://t.co/Z0bxsXCmKl #NCT00352846 #lymsm #BoneHealth #SuppOnc https://t.co/XrU3IRuZ6L"]
[6.205472469329834, 9.528773307800293, "Osteopenia &amp; osteoporosis in untreated non-Hodgkin's lymphoma Pts: An important &amp; potentially treatable survivorship issue in lymphoma [2007] @mtmdphd , Huen, Toth... et al. Hagemeister #ASCO07 Abs 9055 https://t.co/3sDqJu7mPX #lymsm #SuppOnc #BoneHealth https://t.co/Gz53tnnqIr"]
[6.123463153839111, 9.583988189697266, "Baseline Osteopenia and Osteoporosis in Untreated Non-Hodgkin\u2019s Lymphoma Patients [Nov 16, 2006] @mtmdphd Huen, Ayers, Toth, Sellin, Hoff, Murphy, Hagemeister #ASH06 e-Abs 4607 https://t.co/0hAjGyytYe #NCT00352846 #lymsm #BoneHealth #SuppOnc"]
[5.831539630889893, 9.64062213897705, "Pretreatment Vitamin D Deficiency Is Associated with Impaired Progression-Free and Overall Survival in Hodgkin Lymphoma [Oct 17, 2019] Borchmann et al. @JCO_ASCO https://t.co/DkKbGT12lx #lymsm #SuppOnc #BoneHealth https://t.co/Ky6o1KFfRO"]
[6.138782024383545, 10.401893615722656, "Vit D Rec upregulation in alloreactive human T cells [July 2012] Joseph et al. @drkomanduri Hum Immunol https://t.co/uPPvPAN6dL #ImmunoOnc #lymsm #BoneHealth"]
[5.940560817718506, 9.829789161682129, "Low Vit D Assoc w/ Inferior Survival in Follicular NHL: #SWOGOnc &amp; LYSA Studies [2015] Kelly et al. @JCO_ASCO https://t.co/XMkXxlbee2 #lymsm #BoneHealth"]
[5.889703750610352, 9.808661460876465, "Vit D insufficiency &amp; prognosis in chronic lymphocytic leukemia (CLL) [Nov 3, 2010] Shanafelt, Drake et al. @MayoLeukemiaMDS @BloodJournal https://t.co/SRQf5tUnut #CLLsm #leusm #SuppOnc #geriheme"]
[5.782686233520508, 9.69137191772461, "Prognostic Implications of Vitamin D in Patients With a Hematologic Malignancy at a Large Health System in Wisconsin [May 26, 2021] Mundt et al. @mtmdphd @AdvocateAurora Scientific Day https://t.co/QzyaM6n0DZ #leusm #lymsm #mmsm #mpnsm https://t.co/tPgo3a3e1S"]
[5.745555400848389, 9.669878959655762, "RT @chanyooncheah: #ASH23 @DrJFriedberg et al Ilyad study: RCT of vitamin D supplementation vs placebo in low tumor burden indolent lymphom\u2026"]
[6.852381229400635, 11.515023231506348, "@RenoHemonc @chanyooncheah @DrJFriedberg It is better to do the RCT and have data rather than competing opinions. It's easy to critique looking back. There was in vitro rationale and a cheap potential therapy. If it DID work it would be a huge benefit. Doing a non-pharma RCT is not easy."]
[7.614257335662842, 14.324649810791016, "In-Depth Characterization of the High Risk-Associated Tumor Immune Landscape in Multiple Myeloma [Dec 10, 2023] Pita-Juarez et al. #ASH23 Abst 648 https://t.co/detvxJVfl3 @theMMRF #NCT01454297 #mmsm #ImmunoOnc https://t.co/bPjra4y8tr"]
[8.482419967651367, 13.280683517456055, "RT @scmedlin: @mtmdphd @MRC_WIMM @UniofOxford @garyigrad @GulZartash @myelomaMD High-risk myeloma is not identified by cytogenetics and fis\u2026"]
[6.679142951965332, 14.584232330322266, "Deep Characterization of Immune Dysfunction in Pts w/ Myeloma &amp; ID of Cellular Biomarkers for Tailored Vaccination Strategies [Dec 10, 2023] Marti\u00adn-Sanchez et al. #ASH23 Abst 643 https://t.co/8smfrjwN4y #mmsm #IDonc #COVID19Vaccine n=177: 28 MM, 53 B-CLPD &amp; 96 HCP &gt;50yo https://t.co/706BC14kFz"]
[6.511716842651367, 14.632312774658203, "Determinants of Neutralizing Antibody Response After SARS CoV-2 Vaccination in Patients With Myeloma [Mar 8, 2022] @AjayNookaMD et al. @JCO_ASCO https://t.co/nFlGvojgGz #mmsm #COVDID19nCancer #COVID19Vaccine #COVID19 #IDonc @WinshipAtEmory https://t.co/2nWmEVFYeE"]
[6.229762077331543, 14.648956298828125, "Real World Third COVID19 Vaccine Dosing and Antibody Response in Patients with Hematologic Malignancies [Jul 18, 2022] @mtmdphd , Hallmeyer, @vrepublic , Liao, @mullane_michael @scmedlin , Copeland, @JimW9200 @JPCRR https://t.co/CnXLOfmBVw #COVID19nCancer #COVID19Vaccine #IDonc https://t.co/hIgW3gxZEc"]
[6.286182403564453, 14.578384399414062, "#COVID19 Severity and Waning Immunity After up to 4 mRNA Vaccine Doses in 73\u202f608 Patients With Cancer and 621\u202f475 Matched Controls in Singapore: A Nationwide Cohort Study [Jul 13, 2023] Tan et al. @JAMAOnc https://t.co/LFq7RoOgcb #COVID19nCancer #COVID19Vaccine https://t.co/O5OlPoKckb"]
[6.3103861808776855, 14.662528991699219, "Characteristics of Patients with Hematologic Malignancies Without Seroconversion Post-COVID19 Third Vaccine Dosing [Feb 14, 2023] Hallmeyer et al. Biology Methods and Protocols https://t.co/uv4vBWbZku #COVID19Vaccine #COVID19nCancer #bmtsm #leusm #lymsm #mmsm #mpnsm #IDonc https://t.co/ajUtXpx88g"]
[8.27599048614502, 13.623069763183594, "Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial [Oct 23, 2019] Drayson et al. @TheLancetOncol  https://t.co/fMV2JK05Lq #IDonc #mmsm #openaccess"]
[7.091443061828613, 14.548650741577148, "Multiple Myeloma IgG Level &amp; Pneumococcal Vaccination Ab Response [Aug 10, 2017] @mtmdphd et al. @JPCRR https://t.co/x5dZNhopn5 #mmsm #ImmunoOnc #IDonc Consider: 1) homogeneous pop, 2/3) validating surrogate tests w/ outcomes, 4) larger n, 5) Epi + biomarker data https://t.co/n8AT1F1UsJ"]
[7.189063549041748, 14.495306015014648, "Multiple Myeloma IgG Level &amp; Pneumococcal Vaccination Ab Response [Aug 10, 2017] @mtmdphd et al. @JPCRR https://t.co/x5dZNhopn5 #mmsm #ImmunoOnc #IDonc https://t.co/WfDyuObk0X"]
[7.266371726989746, 14.499929428100586, "Multiple Myeloma Vaccination Patterns in a Large Health System: A Pilot Study [4/25/17] Alemu et al. @JPCRR https://t.co/Wg1P0fN1M2 #mmsm #IDonc\n58% PV in the past 5 years.\nFV 15% optimal, 52% suboptimal &amp; 33% none.\n444 hospitalizations &amp; $23M for 204 Pts over 2-year follow-up https://t.co/0qB4jmh6SC"]
[7.388923645019531, 14.404350280761719, "Vaccination in Multiple Myeloma: Review of Current Literature [Jun 8, 2016] Alemu et al. @mtmdphd CLML https://t.co/bhwKr0nDDw #mmsm #ImmunoOnc #IDonc"]
[6.29530143737793, 14.673338890075684, "BMT w/in 4 wks of Sars-Cov-2 Infection Is Associated with Increased Risk of Mortality: A National COVID Cohort Collaborative Study [Sat, Dec 10, 2022] @MeeraMohanMD Abst 387 #ASH22 https://t.co/4MtPzSAUAs #COVID19nCancer #bmtsm #IDonc #COVID19 #AMLsm #leusm OR 49.6"]
[6.696278095245361, 14.486053466796875, "Immune cell differences between patients in different stages of monoclonal plasma cell disorders - Ho et al. #ASCO22 Abstract 8065 https://t.co/3lqJdyhlpy #ImmunoOnc #mmsm"]
[7.025364875793457, 14.59656810760498, "Rates of Influenza and Pneumococcal Vaccination and Correlation with Survival in Multiple Myeloma Patients [Dec 6, 2022] @mtmdphd et al. @AjaiChari CLML https://t.co/kUQeRmdKWV #NCT02761187 #mmsm #IDonc #ClinicalTrials #caxtx https://t.co/ejqMCT4qn4"]
[8.56103229522705, 13.350364685058594, "Targeted NGS Panel Guides Risk-Adapted Treatment Intention in Newly Diagnosed Myeloma Patients [Sun, Dec 10, 2023: 4:45 PM] Agarwal et al. @MRC_WIMM @UniofOxford #ASH23 Abstract 644 https://t.co/EisaCf2EhO #mmsm #PrecisionMedicine https://t.co/aZxLaNiFc4"]
[8.72261905670166, 12.486333847045898, "2022 Myeloma / Plasma Cell Dyscrasia ~ #ASH22Top10 (or so) #mmsm #mmMRD #ASH22 - @mtmdphd *DRAFT* Table Update: Dec 10, 2022 v2 cc @grpetersen1 &amp; @Mohty_EBMT @VincentRK + @MyelomaTeacher @IreneGhobrial https://t.co/WAOVuceT0m"]
[10.840999603271484, 12.112688064575195, "RT @ASH_hematology: See what's in store for #ASH23! View the abstracts selected now: https://t.co/0rBtyUOSqn\n\nExperience the science in San\u2026"]
[6.853994846343994, 8.52588176727295, "RT @DrChoueiri: Voting for the ASCO Election is now open. I am honored to be running as one of the candidates for the Board of Directors Un\u2026"]
[6.969236373901367, 8.934374809265137, "RT @Lymphoma_Doc: Hey @ASCO! \nThe ASCO Election is open, and I am humbled to be a candidate for the Board of Directors. \nClick \u2b07\ufe0f to learn\u2026"]
[10.098865509033203, 12.387628555297852, "@Biotech2050 @ASH_hematology Yes, but I usually focus on myeloma and other plasma cell dyscrasias."]
[8.9793062210083, 9.915276527404785, "RT @doctorpemm: \ud83d\udc49\ud83d\udc49\ud83d\udc49Kicking off the 15th International NYC MPN meeting with Dr Silver\u2019s opening remarks and with great friends &amp; colleagues\u2026"]
[10.0286865234375, 12.321829795837402, "@RahulBanerjeeMD @mshadman @ASH_hematology @fredhutch @ASHClinicalNews @szusmani @Myeloma_Society Some of us have been saying this for a while. \ud83d\ude00"]
[10.633880615234375, 11.57747745513916, "RT @RahulBanerjeeMD: @mshadman @ASH_hematology @fredhutch @ASHClinicalNews Noooooo please stomp out the extra digits and go with #ASH23! Ea\u2026"]
[10.847466468811035, 11.097389221191406, "RT @RahulBanerjeeMD: Trying to move on this preemptively - only with all of your help can we finally have a unified hashtag for #ASH23!\n\nSe\u2026"]
[6.771605491638184, 12.926074981689453, "RT @EagleMyeloma: Revised definition of light chain monoclonal gammopathy from #iStopMM, coming up #ASH23.  Love it.  #mmsm https://t.co/V0\u2026"]
[7.06827974319458, 10.16156005859375, "CHIP, ICUS, CCUS and other four-letter words [Jun 8, 2017] Bejar @LeukemiaJnl https://t.co/KIC78XHsHd #leusm #mdssm #camoldx https://t.co/jOCTIBC1at"]
[8.446564674377441, 12.39409065246582, "Cytopenias + mutations \u2212 dysplasia = what? [11/19/15] - @DavidSteensma @BloodJournal https://t.co/Ifl1sPjgGV #leusm #mdssm #camoldx"]
[9.977330207824707, 12.014785766601562, "The Challenge of Unexplained Splenomegalies: Preliminary Data of the French Prospective Multi-Center Splenomegaly Study (SMS) [Nov 29, 2018] Guillaume Denis, MD etal. @BloodJournal 32 (Supplement 1): 4815 #ASH18 https://t.co/N0PeoI1agT #SMUS"]
[5.938952445983887, 11.03519058227539, "RT @RahulBanerjeeMD: This is fascinating!! We talk about \u201cCAR-pools\u201d of two mono-targeted CARs infused together, or of tec/tal combos in #M\u2026"]
[10.410970687866211, 7.873887538909912, "RT @bdermanmd: One of those days... https://t.co/RfQymjrgly"]
[9.49761962890625, 8.413529396057129, "RT @NicoGagelmann: @doctorpemm @MDAndersonNews @DrHKantarjian @mkonople @mpdrc @GCC_Cortes @NitinJainMD @DavidFajgenbaum @BldCancerDoc @abe\u2026"]
[8.787267684936523, 10.43823528289795, "RT @marklewismd: \u201cPeer\u201d review can mean the doctor who prescribed your medication has to argue on your behalf with a doctor who:\n1) doesn\u2019t\u2026"]
[6.671164512634277, 10.348357200622559, "RT @TempusLabs: We're excited to announce our new ctDNA assay, xF Monitor, which detects and monitors changes in circulating tumor fraction\u2026"]
[8.700287818908691, 11.105995178222656, "RT @jeff_sharman: To any doctor practicing medicine:\n\nThis video gives us a 45 second call to action with concrete step to take.  It is a m\u2026"]
[7.8570356369018555, 10.710996627807617, "RT @VincentRK: I want prior authorization to end. People pay insurance premiums so they can get the care their doctors recommend when they\u2026"]
[6.599571704864502, 9.56820297241211, "RT @Lymphoma_Doc: This is so important: Prior Authorization is often abused to delay justified treatment/tests. @ASCO and others have advoc\u2026"]
[6.877655982971191, 10.550076484680176, "#ImmunoOnc https://t.co/0BOB0dGSFF"]
[5.952293872833252, 14.24814510345459, "#COVID19CP cc @COVID19nCCC https://t.co/xxgbTltZGn"]
[7.275495529174805, 12.144989013671875, "RT @tobyeyre82: Standout abstract by A. Kumar et al \nTP53 mut #MCL\nN=25\nObin-Ven-Zanu (BOVen) regimen\nMRD-stopping rules at 24m\nORR 95%\nCR\u2026"]
[6.736422061920166, 10.87723159790039, "RT @DrSteveMartin: When molecular testing just does not yield an actionable target and you go with chemo instead\n#lcsm https://t.co/HHLkZKD\u2026"]
[6.9615278244018555, 9.2577543258667, "RT @Lymphoma_Doc: The @ASCO LDP is awesome, training tomorrow\u2019s leaders to ensure ASCO continues to thrive and help our patients. @DrSGraff\u2026"]
[6.722743511199951, 11.508405685424805, "RT @MeeraMohanMD: Check out our oral abstract on AEs and NRM with BCMA directed therapies in MM #mmsm #ASH23 @MCWCancerCenter \nhttps://t.co\u2026"]
[8.483129501342773, 13.373783111572266, "Targeted NGS Panel Guides Risk-Adapted Treatment Intention in Newly Diagnosed Myeloma Patients [Sun, Dec 10, 2023: 4:45 PM] Agarwal et al. #ASH23 Abstract 644 https://t.co/EisaCf2EhO #mmsm #PrecisionMedicine"]
[5.928618431091309, 14.171228408813477, "RT @COVID19nCCC: @mtmdphd @ACasadevall1 @US_FDA It is 11/8/23..."]
[5.977609157562256, 14.333426475524902, "MT @ACasadevall1 [Mar 13, 2023] Good news: @US_FDA extended the EUA for COVID-19 convalescent plasma (#COVID19CP) until 11/7/2023. This is important b/c w/ the impending end of the emergency, EUAs could also end, &amp; CCP is the only antibody based therapy for the immunocompromised"]
[5.975757122039795, 14.30785083770752, "Convalescent Plasma EUA Letter of Authorization [Dec 28, 2021] @US_FDA https://t.co/3zZCFJUV6n #COVID19CP #COVID19 #CCC19 #COVID19nCancer #IDonc @COVID19nCCC @ShohamTxID @DrMJoyner @ACasadevall1 @DrJPHenderson @jwsenefeld @hartman_bill @StephenAKlassen @rubinstein_md\n\n\ud83d\udcf7\n /// https://t.co/IA39OflP0R"]
[6.0863566398620605, 14.48142147064209, "COVID-19 Convalescent Plasma for the Treatment of Immunocompromised Patients: A Systematic Review and Meta-analysis [Jan 12, 2023] @jwsenefeld et al. @ACasadevall1 @DrMJoyner @JAMANetworkOpen https://t.co/MozmCs6W0q #COVID19CP #COVID19"]
[6.027195930480957, 14.435389518737793, "Early Outpatient Treatment for Covid-19 with Convalescent Plasma [Mar 30, 2022] @jhDavidSullivan et al. @NEJM https://t.co/Cqht9CiZSK #NCT04373460 #COVID19CP #COVID19"]
[6.088365077972412, 14.474076271057129, "Convalescent Plasma and Survival in Hematologic Malignancy and COVID-19 [Jun 17, 2021] @mtmdphd &amp; @DrJPHenderson et al. @jwsenefeld @DrDimpyShah @hemoncwarner @COVID19nCCC - @JAMAOnc https://t.co/g3GP7Ets4q #COVID19CP #CCC19 #COVID19nCancer #COVID19 #IDonc https://t.co/xiakLJkFTg"]
[6.208511829376221, 14.672718048095703, "Patients recently treated for B-lymphoid malignancies show increased risk of severe COVID-19: a #CCC19 registry analysis [Mar 9, 2022] @rubinstein_md et al. @mtmdphd @COVID19nCCC @BCD_AACR https://t.co/IMEbvgZI4Q #COVID19nCancer #COVID19 #bmtsm #leusm #lymsm #mmsm #mpnsm https://t.co/u7Un4hmZmy"]
[6.239551544189453, 14.641997337341309, "Severity of Sars-Cov-2 Infection in Pts w/ Hematologic Malignancies: A COVID-19 &amp; Cancer Consortium (#CCC19) Registry Analysis - @rubinstein_md et al. @mtmdphd @COVID19nCCC #ASH20 Abstract 1632 https://t.co/QiprV4WH2O #leusm #lymsm #mmsm #mpnsm #IDonc n=757 w/ #COVID19nCancer"]
[6.473780632019043, 14.62391185760498, "Determinants of Neutralizing Antibody Response After SARS CoV-2 Vaccination in Patients With Myeloma [Mar 8, 2022] @AjayNookaMD et al. @JCO_ASCO https://t.co/nFlGvojOw7 #mmsm #COVDID19nCancer #COVID19Vaccine #COVID19 #IDonc @WinshipAtEmory https://t.co/7sklZaS2n7"]
[8.193702697753906, 13.885476112365723, "Clinician survey regarding measurable residual disease-guided decision-making in multiple myeloma [Jul 11, 2022] @bdermanmd @ajjakubowiak @mtmdphd @BloodCancerJnl https://t.co/oioEadi46u #mmMRD #mmsm #openaccess https://t.co/jwdAVYyToa"]
[8.112103462219238, 13.973702430725098, "Clinician attitudes and practices toward measurable residual disease in multiple myeloma [Jun 7, 2020] @bdermanmd @jagoda_jasielec @ajjakubowiak Brit J Haematol https://t.co/8zhxYfZ4Po #mmsm #mmMRD https://t.co/Y2dpIpZABx"]
[8.012351036071777, 13.952603340148926, "#mmMRD healthcare social media hashtag [Nov 21, 2020] Minimal/measurable residual disease (MRD) in multiple myeloma. Submitted by @bdermanmd to @symplur @healthhashtags https://t.co/grkkioxAnP #mmsm"]
[7.985231399536133, 14.000298500061035, "Patient perspectives on BCMA-targeted therapies for multiple myeloma: A survey conducted in a patient advocacy group [@HealthtreeMM] - @AhlstromJenny et al. #ASCO23 Abstract 2582 https://t.co/JqM8VqmO2t #mmsm #CARTcell #ImmunoOnc HT @RahulBanerjeeMD"]
[8.033834457397461, 13.942809104919434, "A survey on the patient perspective on cure in multiple myeloma [Oct 9, 2022] @ManniMD1 et al. @HealthtreeMM @TheLancetHaem\nhttps://t.co/1XhKT7BuvQ #mmsm"]
[8.899062156677246, 13.542875289916992, ".@HealthtreeMM Hub: A Patient-Derived, Patient-Driven Clinical Cancer Information Platform Used to Overcome Hurdles &amp; Accelerate Research in Multiple Myeloma [3/10/22] @NSweeneyPhd @AhlstromJenny @FaithEDavies1 @mtmdphd @JCOCCI_ASCO https://t.co/WOwLb9EWp3 @myelomacrowd #mmsm https://t.co/UT0ZnPTwPG"]
[8.712471961975098, 9.878889083862305, "Healing the Body and the Soul: Becoming a Patient Again [Nov 5, 2021] by @AhlstromJenny @HealthtreeMM https://t.co/7tBZ8didP8 #mmsm https://t.co/9zL8wv7Q3m"]
[8.567160606384277, 12.773691177368164, ".@HealthtreeMM Patient Portal mediated myeloma patient-reported vaccination and antibiotic use - @mtmdphd @AhlstromJenny @NSweeneyPhd J Clin Oncol 38: 2020 (suppl; abstr e20567) #ASCO20 https://t.co/MwCOajVQ2R #mmsm #IDonc https://t.co/EI3iPg7k8o"]
[8.50451374053955, 12.943426132202148, ". @HealthtreeMM Patient Portal mediated myeloma patient reported diagnostic imaging and pathology testing - @NSweeneyPhd @AhlstromJenny @mtmdphd J Clin Oncol 38: 2020 (suppl; abstr e20565) #ASCO20 https://t.co/CRLXETpMBU #mmsm #oncorad #oncopath https://t.co/huJ1CtP71Y"]
[7.594332695007324, 8.488234519958496, "RT @ASCOPres: Congratulations to Dr. Monica Bertagnolli on her confirmation as @NIH Director. A truly extraordinary leader for this role. L\u2026"]
[7.689394950866699, 8.426227569580078, "RT @DanaFarber: Congratulations to Monica Bertagnolli, MD, on being confirmed by the U.S. Senate to lead the @NIH. \n\nAs leader of the @theN\u2026"]
[6.6835222244262695, 11.818717956542969, "Sonrotoclax (BGB-11417) + Dex for Tx RRMM w/ t(11;14): Safety, Efficacy, and Determination of Recommended Phase 2 Dose [Mon, Dec 11, 2023 5p] @HangQuach1 et al. @bhemato #ASH23 Abs 1011\nhttps://t.co/V9OLUSP0l3 #mmsm #PrecisionMedicine #caxtx https://t.co/fJ608zcUxF"]
[6.668990135192871, 14.582799911499023, "Deep Characterization of Immune Dysfunction in Pts w/ Myeloma &amp; ID of Cellular Biomarkers for Tailored Vaccination Strategies [Dec 10, 2023] Marti\u00adn-Sanchez et al. #ASH23 Abst 643 https://t.co/8smfrjxkU6 #mmsm #IDonc #COVID19Vaccine n=177: 28 MM, 53 B-CLPD &amp; 96 HCP &gt;50yo"]
[7.608109474182129, 14.33456802368164, "In-Depth Characterization of the High Risk-Associated Tumor Immune Landscape in Multiple Myeloma [Dec 10, 2023] Pita-Juarez et al. #ASH23 Abst 648 https://t.co/detvxJVNaB @theMMRF #NCT01454297 #mmsm #ImmunoOnc https://t.co/4DVl6cASOX"]
[8.378249168395996, 13.308899879455566, "Targeted NGS Panel Guides Risk-Adapted Treatment Intention in Newly Diagnosed Myeloma Patients [Sun, Dec 10, 2023: 4:45p] Agarwal et al. @MRC_WIMM @UniofOxford #ASH23 Abstract 644 https://t.co/EisaCf3c7m #mmsm #PrecisionMedicine https://t.co/i7rAiNq9ym"]
[7.640008926391602, 8.41506290435791, "RT @NeliMUlrich: Thrilled about the senate confirmation of @NCIDirector today as the new head of @NIH ! We\u2018re looking forward to advancing\u2026"]
[6.652499198913574, 11.828054428100586, "RT @bhemato: Phase I results of Sonrotoclax in t (11;14) in RRMM; safe and promising efficacy with 70% ORR in TCE pts. Look forward to get\u2026"]
[10.45487117767334, 8.884774208068848, "#mmsm #geriheme #gerionc https://t.co/Nmmxj7kGKv"]
[6.886214733123779, 8.381824493408203, "RT @n8pennell: Hard to believe but it\u2019s that time again! Abstract Submission for #ASCO24 is open, deadline is Feb 6, 2024.  https://t.co/Mu\u2026"]
[8.04174518585205, 12.991307258605957, "Real-world analysis of D-RVd v. RVd at induction for newly diagnosed transplant eligible multiple myeloma patients [May 31, 2023] @JayHydren @NSweeneyPhd et al. @AhlstromJenny @HealthtreeMM #ASCO23 Abst e20024\nhttps://t.co/WHttKGy7mN #mmsm #RWD"]
[8.645744323730469, 13.541824340820312, "Circulating tumor DNA, and clinical features to guide rechallenge with BRAF inhibitors in BRAF-V600E mutated metastatic colorectal cancer [Oct 20, 2023] @Javier_RosMD et al. @Annals_Oncology https://t.co/2zJtEf1jwr #crcsm #LiquidBiopsy #PrecisionMedicine https://t.co/JyR8ci6NuG"]
[7.1061110496521, 8.361029624938965, "RT @AshleySumrallMD: Wow! There are so many incredible candidates running for @ASCO positions in this year's election. I just would love to\u2026"]
[7.683004379272461, 13.448742866516113, "#EAonc EAA173 - Daratumumab to Enhance Therapeutic Effectiveness of Revlimid in Smoldering Myeloma (DETER-SMM) - PI: @nsc_natalie https://t.co/VtBMJUkfVv\nActivated: Apr 30, 2019 #mmsm @eaonc #NCT03937635 @VincentRK @mweissmdphd https://t.co/xf12zaIh93"]
[7.809178352355957, 13.735991477966309, ". @SWOG S1803 Ph3 Len +/- Daratumumab/rhuph20 as Post-ASCT Maintenance in Myeloma Using Minimal Residual Disease (#mmMRD) to direct Therapy Duration (DRAMMATIC) - @DoctorAKrishnan Hoering, @Phari Sexton, @Myeloma_Doc #ASH20 Abst 1515 https://t.co/IeLcOeiugZ #NCT04071457 #mmsm https://t.co/WPwqBswdH9"]
[7.731738567352295, 12.740941047668457, "#EAOnc EQUATE EAA181 Effective Quadruplet Utilization After Tx Evaluation: Ph3 RCT NDMM Not Intended for Early ASCT [Activated: 10/27/20] PI= @myelomaMD https://t.co/qD26HMxByG #NCT04566328 #mmMRD #mmsm @eaonc @mweissmdphd @VincentRK @LynneWagnerPhD Wei Snyder Kostakoglu @mtmdphd https://t.co/5n44K0uK4d"]
[8.95640754699707, 13.613443374633789, ".@HealthtreeMM Hub: A Patient-Derived, Patient-Driven Clinical Cancer Information Platform Used to Overcome Hurdles &amp; Accelerate Research in Multiple Myeloma [3/10/22] @NSweeneyPhd @AhlstromJenny @FaithEDavies1 @mtmdphd @JCOCCI_ASCO https://t.co/WOwLb9EWp3 @myelomacrowd #mmsm https://t.co/ZLTqdXrhij"]
[8.739527702331543, 9.865341186523438, "Healing the Body and the Soul: Becoming a Patient Again [Nov 5, 2021] by @AhlstromJenny @HealthtreeMM https://t.co/7tBZ8didP8 #mmsm https://t.co/d2W46p4kiY"]
[8.608312606811523, 12.792054176330566, ".@HealthtreeMM Patient Portal mediated myeloma patient-reported vaccination and antibiotic use - @mtmdphd @AhlstromJenny @NSweeneyPhd J Clin Oncol 38: 2020 (suppl; abstr e20567) #ASCO20 https://t.co/MwCOajVQ2R #mmsm #IDonc https://t.co/hx3lVbtsW8"]
[8.661211967468262, 12.929057121276855, ". @HealthtreeMM Patient Portal mediated myeloma patient reported diagnostic imaging and pathology testing - @NSweeneyPhd @AhlstromJenny @mtmdphd J Clin Oncol 38: 2020 (suppl; abstr e20565) #ASCO20 https://t.co/CRLXETpMBU #mmsm #oncorad #oncopath https://t.co/PuPcxOqALn"]
[8.031611442565918, 9.612768173217773, "@Rfonsi1 @BloodAdvances @RahulBanerjeeMD Likely not in all, but often treat the cancer and the frail improve."]
[10.43795108795166, 8.604068756103516, "Excellent video https://t.co/U5WI3piSqy"]
[10.225430488586426, 8.642778396606445, "RT @GraemePeacock1: A composite of the 5x most requested images of a tree at night. I just wish I\u2019d taken the time &amp; effort to do some more\u2026"]
[8.408567428588867, 13.920267105102539, "RT @MyelomaEurope: Did you know myeloma diagnosis may require over four medical consultations?  Help improve diagnosis by sharing the myelo\u2026"]
[9.637744903564453, 8.027390480041504, "RT @GraemePeacock1: For heavens sake Northumberland, put it away immediately. No one likes a show-off :) https://t.co/N2MCoInCp3"]
[9.383499145507812, 7.907980442047119, "@GraemePeacock1 Beautiful Lindisfarne!"]
[9.94164752960205, 8.654831886291504, "Great photo \u2018young\u2019 @DrRakeshPopat https://t.co/VB0RO4rATl"]
[8.961098670959473, 12.260839462280273, "Congratulations everyone @GWH_NHS      It is a nice verification of the fantastic service you offer your myeloma patients @MyelomaUK https://t.co/cEMmgLVnk7"]
[7.508477687835693, 11.965556144714355, "RT @BloodJournal: Postransplant maintenance with lenalidomide and dexamethasone resulted in a 6-year PFS of 61.3%, with no benefit of addin\u2026"]
[10.323626518249512, 10.88879680633545, "RT @MyelomaUK: \ud83e\uddf51/2 We're excited to announce that we're attending the American Society of Haematology annual meeting (ASH) in December! #A\u2026"]
[9.138030052185059, 12.600773811340332, "RT @VincentRK: Kudos to the International Myeloma Society (IMS) for sending a survey to its members on ABIM MOC. Please participate! \n\n@Mye\u2026"]
[7.92930269241333, 12.450762748718262, "RT @mtmdphd: More intensive therapy [VRd vs Rd] has a better effect for frail Pts with multiple myeloma [Oct 13, 2023 ] DuMontier et al. @B\u2026"]
[10.043088912963867, 10.395856857299805, "RT @COMyCongress: \ud83d\udce2We are excited to announce the dates for our\nnext COMy Congress \nMay 23-26, 2024 \nParis &amp; Online\n\n\u2728This is a very specia\u2026"]
[9.517946243286133, 9.445089340209961, "Eric and Betty married 73 years today! There are no words to match this achievement! https://t.co/x1sHSFEBnW"]
[8.769316673278809, 10.667737007141113, "RT @Eddie_Cliff: A very special, and very different, episode of @BloodCancerTalk - have a listen and let us know what you think \n\nDr Raza e\u2026"]
[8.447031021118164, 14.32180118560791, "Amazing thread on WB DW-MRI by @MyMKaiser! IMO, we should almost never make a diagnosis of Smoldering Myeloma or Solitary Plasmacytoma without a baseline WB DW-MRI, unless contraindication to MRI. https://t.co/oWsx97pKdd"]
[8.82104778289795, 11.128565788269043, "RT @BloodCancerTalk: Our new episode with @AzraRazaMD just dropped. \nDr. Raza gives a masterclass on how she approaches difficult situation\u2026"]
[9.72882080078125, 10.093562126159668, "RT @BloodCancerTalk: BCT team meeting to celebrate @AshKishtagari being in NYC for an MPN meeting \ud83e\udd73\n\nMore exciting episodes coming soon: ly\u2026"]
[8.312386512756348, 9.58361530303955, "@DrNikitaMehra @CancerGridIndia @csoncol Indeed, @VPrasadMDMPH has played a pivotal role in bringing critical appraisal to the mainstream in oncology! Countless trainees have learnt from his work how to critically read a clinical trial manuscript (I am certainly one of them)!"]
[9.58702564239502, 8.198382377624512, "@barttels2 @AaronGoodman33 @marklewismd @AshKishtagari @EddiesTPWorld @BloodCancerTalk Thanks for listening! Glad you liked it."]
[6.752225399017334, 11.3440523147583, "RT @TheLancetHaem: \"With the emergence of highly effective clone-directed therapies, where does HDM-AHCT fit in the treatment framework of\u2026"]
[6.422382831573486, 11.910880088806152, "RT @MeeraMohanMD: Check out our oral abstract on efficacy and safety of standard-of-care teclistamab\n#mmsm #ASH23 @MCWCancerCenter \n@rajshe\u2026"]
[8.553646087646484, 14.2725830078125, "RT @MyMKaiser: Comment to Q1: No contrast needed for myeloma WB-MRI with diffusion weighting (MY-RADS, below). Also, no ionising radiation\u2013\u2026"]
[9.390604972839355, 10.459372520446777, "Excited to have @MorieGertz talk about AL #Amyloidosis at @columbiacancer grand rounds today!\n@CAMPamyloidosis @SLentzsch https://t.co/fotQQuAfAk"]
[7.184751510620117, 13.035823822021484, "@SusanBal9 @bdermanmd Interesting. I always feel nihilistic about re-induction, but maybe it works sometime. Would be great to have published real-works data on this."]
[9.688770294189453, 7.645394325256348, "@RahulDoc2 None IMO"]
[7.713975429534912, 13.788724899291992, "@drkomanduri Dex is typically no longer used in the maintenance setting in myeloma (an Italian RCT showed no benefit of adding steroids to Len in maintenance). So single agent Len rules for most."]
[7.139988422393799, 11.97159194946289, "@AaronGoodman33 The MRD-conversion rate was no better in the ixazomib arm. It didn\u2019t do much other than GI toxicities :)"]
[6.997215270996094, 11.966631889343262, "This trial serves as an important reminder for the fact that ixazomib should have NO role in post-transplant maintenance  in the current era! Adds GI toxicities without even a PFS benefit!\n#mmsm https://t.co/LxHt7HTkHm"]
[8.493854522705078, 10.394384384155273, "Next up @tanyawildes is talking about physiology of aging and supportive care measures in #mmsm @MyelomaCanada @NBahlis @akeithstewart @HiraSMian @thanosdimop https://t.co/Vjwp1mLjFI"]
[8.977449417114258, 12.849129676818848, "RT @Myeloma_Society: Calling all #Myeloma researchers! \ud83d\udd14Take advantage of this amazing opportunity - apply for the IMS Translational Resear\u2026"]
[8.149521827697754, 12.52708911895752, "Managing pts with myeloma and renal failure #mmsm @MyelomaCanada @NBahlis @akeithstewart @thanosdimop @Dr_AdrianaRossi https://t.co/XHfhV6tg5B"]
[10.831997871398926, 11.963495254516602, "RT @UrviShahMD: ASH Annual Meeting Abstracts out now #ASH23 @ASH_hematology @ASHClinicalNews \n\nhttps://t.co/LDRiV3ia9Y"]
[10.23121452331543, 12.106607437133789, "RT @ASH_hematology: @RahulBanerjeeMD @mshadman @fredhutch @ASHClinicalNews @szusmani @Myeloma_Society Yes, it's #ASH23! See you there!"]
[10.111122131347656, 9.176108360290527, "RT @HiraSMian: Sharing a stage with the legendary @tanyawildes at @MyelomaCanada meeting https://t.co/oPl2U7qZet"]
[8.635568618774414, 7.911940097808838, "RT @nytimes: The New York City Marathon is underway. Follow our live updates from all five boroughs and find the best spots to watch. https\u2026"]
[8.767855644226074, 7.913276672363281, "RT @FredsTeam: Fred\u2019s Team takeover in Times Square! We\u2019re coming for you, @nycmarathon! #FredsTeam #TCSNYCMarathon https://t.co/d7dgYSqRlK"]
[8.900561332702637, 8.341625213623047, "RT @MalinHultcrantz: Come cheer for us today!! @FredsTeam @szusmani @MSKCancerCenter #mmsm"]
[8.577658653259277, 8.37429428100586, "Thanks for the donations to our #mmsm team, looks like a great day for some running! TCS New York City Marathon: MyelomaStompers - Fred's Team @FredsTeam @MalinHultcrantz @MSKCancerCenter \u2014 one last call for those #medtwitter folks who want to contribute \ud83d\udc47\ud83c\udffd\u2026 https://t.co/LGnnJVSwnN"]
[8.960843086242676, 8.524012565612793, "@MalinHultcrantz @FredsTeam @MSKCancerCenter Strong work Malin!!"]
[7.411087989807129, 10.98784351348877, "RT @sardesai_sagar: Excellent presentation demonstrating plant-based high fiber dietary intervention can reduce risk of progression in SMM\u2026"]
[8.801825523376465, 9.274480819702148, "RT @UrviShahMD: Congratulations @sardesai_sagar @JasmineSukumar @maryam_lustberg \nEnjoyed hearing about the initial stages of your trial at\u2026"]
[8.736286163330078, 13.168381690979004, "RT @Myeloma_Society: It's never too early to get ready for the 5th Immune Effector Cell Therapies Workshop in #Boston next year! Join the I\u2026"]
[9.6566743850708, 9.842522621154785, "RT @UrviShahMD: Look forward to talks with amazing speaker line up at the @IMFmyeloma African American Initiative Council meeting @jmikhael\u2026"]
[9.14057731628418, 8.513208389282227, "RT @agarwalonc: @JoshuaRichterMD @TischCancer @MountSinaiNYC True inspiration for so many of us!!!"]
[8.760544776916504, 9.587597846984863, "RT @JoshuaRichterMD: The goal is cure !    Words to live by from Dr Sundar Jagannath who is being honored today the CFS meeting.    An insp\u2026"]
[7.788504600524902, 8.413728713989258, "RT @NIHDirector: It is a privilege to serve as the 17th Director of @NIH. I'm committed to the #NIH mission in advancing knowledge through\u2026"]
[9.35698127746582, 10.54687786102295, "RT @BU_Amyloidosis: Your generous contributions to The Amyloidosis Center would be greatly appreciated this Giving Tuesday. Mark your calen\u2026"]
[9.352649688720703, 10.56653118133545, "RT @BU_Amyloidosis: Your generous contributions to The Amyloidosis Center would be greatly appreciated this Giving Tuesday. Mark your calen\u2026"]